+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 53708

Chapter 53708 contains a list of PDF Full Texts available from EurekaMag.





Lv, G-Dong.; Liu, T.; Lin, R-Yong.; Wang, X.; Wang, J-Hua.; Ren, Z-Hui.; Wen, H.; Lu, X-Mei., 2010:
Immunoreactivity of the recombinant protein of Echinococcus granulosus antigen B

Cossu, M.; Isola, M.; Solinas, P.; De Lisa, A.; Massa, D.; Lantini, M.S., 2011:
Immunoreactivity of the salivary protein statherin in human male accessory sex glands

Adanina, V.O.; Rio, J.P.; Adanina, A.S.; Reperan, J.; Veselkin, N.P., 2009:
Immunoreactivity of the synapses on the primary afferent axons and sensory neurons of the spinal cord Lampetra fluviatilis

Nemolato, S.; Cabras, T.; Fanari, M.U.; Cau, F.; Fanni, D.; Gerosa, C.; Manconi, B.; Messana, I.; Castagnola, M.; Faa, G., 2011:
Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract

Shen, S.; Wang, F.; Chen, L.; Wang, T.; Hu, Y.; Zhang, X., 2012:
Immunoreactivity of two novel monoclonal antibodies against human inducible co-stimulator ligand

Gatto, F.; Feelders, R.A.; van der Pas, R.; Kros, J.M.; Waaijers, M.; Sprij-Mooij, D.; Neggers, S.J.C.M.M.; van der Lelij, A-Jan.; Minuto, F.; Lamberts, S.W.J.; de Herder, W.W.; Ferone, D.; Hofland, L.J., 2013:
Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly

Paine, S.; Bedford, L.; Thorpe, J.R.; Mayer, R.John.; Cavey, J.R.; Bajaj, N.; Sheppard, P.W.; Lowe, J.; Layfield, R., 2009:
Immunoreactivity to Lys63-linked polyubiquitin is a feature of neurodegeneration

Rašković, S.; Matić, I.Z.; Dorđić, M.; Damjanović, A.; Kolundžija, B.; Grozdanić-Stanisavljević, Nđa.; Besu, I.; Jovičić, Z.; Bijelić, B.; Janković, L.; Juranić, Z., 2015:
Immunoreactivity to food antigens in patients with chronic urticaria

Alibardi, L., 2014:
Immunoreactivity to the pre-core box antibody shows that most glycine-rich beta-proteins accumulate in lepidosaurian beta-layer and in the corneous layer of crocodilian and turtle epidermis

Machado, I.; Mayordomo-Aranda, E.; Scotlandi, K.; Picci, P.; Llombart-Bosch, A., 2015:
Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection

Esteve-Turrillas, F.A.; Agulló, C.; Abad-Fuentes, A.; Abad-Somovilla, A.; Mercader, J.V., 2012:
Immunoreagent generation and competitive assay development for cyprodinil analysis

Abad-Fuentes, A.; Agulló, C.; Esteve-Turrillas, F.A.; Abad-Somovilla, A.; Mercader, J.V., 2014:
Immunoreagents and competitive assays to fludioxonil

Samelson, L.E., 2012:
Immunoreceptor signaling

Daëron, M.; Jaeger, Sébastien.; Du Pasquier, L.; Vivier, E., 2008:
Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future

Tourdot, B.E.; Brenner, M.K.; Keough, K.C.; Holyst, T.; Newman, P.J.; Newman, D.K., 2013:
Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1

Jakus, Zán.; Fodor, S.; Abram, C.L.; Lowell, C.A.; Mócsai, A., 2007:
Immunoreceptor-like signaling by beta 2 and beta 3 integrins

Esposito, A.; Leti, W.; Fantauzzi, A.; Pastori, D.; Isgro, A.; Aiuti, F.; Mezzaroma, I., 2010:
Immunorecovery after prolonged HIV-related immunosuppression: opportunities of the new antiretroviral classes

Chen, Z-Gui.; Ji, J-Zhi.; Li, M.; Chen, Y-Feng.; Chen, F-Hua.; Chen, H., 2007:
Immunoregulants improves the prognosis of infants with wheezing

Charron, D.; Al-Daccak, R., 2014:
Immunoregulation and allogenicity in cardiac stem cell regenerative therapy

Knechtle, S.J., 2011:
Immunoregulation and tolerance

Sinclair, N.R.; Panoskaltsis, A., 1987:
Immunoregulation by Fc signals A mechanism for self-nonself discrimination

Peón, A.N.; Espinoza-Jiménez, A.; Terrazas, L.I., 2013:
Immunoregulation by Taenia crassiceps and its antigens

Wagner, A.; Förster-Waldl, E.; Garner-Spitzer, E.; Schabussova, I.; Kundi, M.; Pollak, A.; Scheiner, O.; Joachim, A.; Wiedermann, U., 2008:
Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice

Miyake, S., 2009:
Immunoregulation by iNKT cells

Sikora, E.; Ptak, Włodzimierz.; Bryniarski, K., 2012:
Immunoregulation by interference RNA (iRNA) - mechanisms, role, perspective

Brock, J.H.; de Sousa, M., 1986:
Immunoregulation by iron-binding proteins

Nielsen, C.H.; Bendtzen, K., 2012:
Immunoregulation by naturally occurring and disease-associated autoantibodies : binding to cytokines and their role in regulation of T-cell responses

Wang, Y.; Zhu, M.; Miller, M.; Fu, Y-Xin., 2009:
Immunoregulation by tumor necrosis factor superfamily member LIGHT

Shen, Z.; Teng, X.; Qian, X.; He, M.; Hu, Y.; Ye, W.; Huang, H.; Yu, Y.; Chen, Y., 2011:
Immunoregulation effect by overexpression of heme oxygenase-1 on cardiac xenotransplantation

Huang, Y.; Zhang, Y.; Li, C.; Jiang, Y.; He, L.; Guo, W.; Guo, M.; Gong, W., 2014:
Immunoregulation effect of crude extract of C. elegans on allergic asthma

Wang, M-Li.; Xie, Z-Gang.; Lu, H.; Shi, M.; Hu, M-Ru.; Yu, M.; Ma, Y-Fang.; Shen, B-Fen.; Guo, N., 2011:
Immunoregulation effects in vitro of the xenoprotein in combination with recombinant human granulocyte-macrophage colony stimulating factor and bacillus Calmette-Guerin

Gao, H-Yi.; Tao, E-Xue.; Wang, Y., 2014:
Immunoregulation effects of Tiaomian No. 3 for recurrent spontaneous abortion caused by shortage of blocking antibodies

Fan, L.; Yu, Z.; Li, J.; Dang, X.; Wang, K., 2015:
Immunoregulation effects of bone marrow-derived mesenchymal stem cells in xenogeneic acellular nerve grafts transplant

Itoh, N.; Itoh, Y.; Tassoni, A.; Ren, E.; Kaito, M.; Ohno, A.; Ao, Y.; Farkhondeh, V.; Johnsonbaugh, H.; Burda, J.; Sofroniew, M.V.; Voskuhl, R.R., 2017:
Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes

Ellner, J.J., 2010:
Immunoregulation in TB: observations and implications

Zielinski, C.E.; Zuberbier, T.; Maurer, M., 2013:
Immunoregulation in cutaneous allergy: prevention and control

Gollob, K.J.; Viana, A.G.; Dutra, W.O., 2014:
Immunoregulation in human American leishmaniasis: balancing pathology and protection

Tournadre, A.; Miossec, P., 2013:
Immunoregulation in idiopathic inflammatory myopathies: from dendritic cells to immature regenerating muscle cells

Colston, M.J., 1984:
Immunoregulation in leprosy

Sargent, I.L.; Borzychowski, A.M.; Redman, C.W.G., 2007:
Immunoregulation in normal pregnancy and pre-eclampsia: an overview

Morecki, S.; Slavin, S., 2011:
Immunoregulation of GVHD by triggering the innate immune system with CpG

Ben, S-bin.; Zhao, H-li.; Ge, Q-zhi.; Dong, Y., 2008:
Immunoregulation of IL-18 in mice with radiated damage

Rose, M.L., 1985:
Immunoregulation of MHC antigen expression

Meenattoor, G.; Balaram, P.; Hareendran, N.; Abraham, T.; Nalinakumari, K.; Nair, M., 1994:
Immunoregulation of T-lymphocytes by autologous serum in oral-cancer

Gorantla, S.; Makarov, E.; Roy, D.; Finke-Dwyer, J.; Murrin, L.Charles.; Gendelman, H.E.; Poluektova, L., 2010:
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS

Xu, D.; Lin, L.; Lin, X.; Huang, Z.; Lei, Z., 2010:
Immunoregulation of autocrine prolactin: suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown

Zheng, L.; Chu, J.; Tan, L.; Shi, Y.; Han, Y., 2013:
Immunoregulation of autologous peripheral blood stem cell transplantation in patients with hepatitis B-related end-stage liver disease

Singh, A.; Mehdi, A.A.; Srivastava, R.N.; Verma, N.Singh., 2012:
Immunoregulation of bone remodelling

Maurya, N.; Gujar, R.; Gupta, M.; Yadav, V.; Verma, S.; Sen, P., 2014:
Immunoregulation of dendritic cells by the receptor T cell Ig and mucin protein-3 via Bruton's tyrosine kinase and c-Src

Lou, Z-Yin.; Zhao, C-Bo.; Xiao, B-Guo., 2012:
Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist

Ishikawa, T., 2012:
Immunoregulation of hepatitis B virus infection--rationale and clinical application

Clark, D.A.; Slapsys, R.M.; Croy, B.A.; Rossant, J., 1984:
Immunoregulation of host-versus-graft responses in the uterus

Takase, O.; Iwabuchi, K.; Quigg, R.J., 2014:
Immunoregulation of inflammation in chronic kidney disease

Liu, M.; Xiao, L.; Liu, S.; Hu, Y.; Tian, J.; Gao, G.; Xie, S.; Guan, Y., 2013:
Immunoregulation of myelin-specific CD4+ T cell response by neural stem/progenitor cells: role of prostaglandin E2

Wax, M.B.; Tezel, Gülgün. , 2009:
Immunoregulation of retinal ganglion cell fate in glaucoma

Wang, W.; Xi, Y-bin.; Chen, G-jie.; Hao, J.; Shen, T-wei.; Wang, B-guo.; Li, W-yi., 2007:
Immunoregulation of vasoactive intestinal peptide on rat Leydig cells

Pflugfelder, S.C.; Stern, M.E.; Beutler, B.A.; Burns, A.R.; Calonge, M.; Chodosh, J.; Dana, M.R.; De Paiva, C.S.; Fleiszig, S.; Hazlett, L.D.; Huang, A.J.; Jones, D.B.; Liu, Y-J.; McDermott, A.M.; Mircheff, A.K.; Niederkorn, J.Y.; Perez, V.; Perlman, E.; Rosenbaum, J.; Theofilopoulos, A., 2009:
Immunoregulation on the ocular surface: 2nd Cullen Symposium

Zhao, L.; Ma, H.; Jiang, Z.; Jiang, Y.; Ma, N., 2014:
Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients

Chakraborty, N.G., 2009:
Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy

Li, H-lun.; Wang, G-you.; Li, G-zhong.; Sun, B.; Zhao, J-cheng.; Kong, Q-fei.; Jin, L-hong.; Wang, D-dan., 2007:
Immunoregulative effect of NK1.1+ cells on the development of experimental autoimmune myasthenia gravis

Hillhouse, E.E.; Delisle, J-Sébastien.; Lesage, S., 2013:
Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer

Shi, B.; Wang, Z.; Jin, H.; Chen, Y.Wei.; Wang, Q.; Qian, Y., 2010:
Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice

Nakai, N.; Katoh, N.; Kitagawa, T.; Ueda, E.; Takenaka, H.; Kishimoto, S., 2009:
Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination

Gaardbo, J.C.; Ronit, A.; Hartling, H.J.; Gjerdrum, L.M.R.; Springborg, K.; Ralfkiær, E.; Thorsteinsson, K.; Ullum, H.; Andersen, Åse.B.; Nielsen, S.D., 2014:
Immunoregulatory T cells may be involved in preserving CD4 T cell counts in HIV-infected long-term nonprogressors and controllers

Nada, A.Mohamed.; Hammouda, M., 2014:
Immunoregulatory T cells, LFA-3 and HLA-DR in autoimmune thyroid diseases

Beyer, M.; Schultze, J.L., 2008:
Immunoregulatory T cells: role and potential as a target in malignancy

Geha, R.S.; Rosen, F.S., 1983:
Immunoregulatory T-cell defects

Mohapatra, S.K.; Guri, A.J.; Climent, M.; Vives, C.; Carbo, A.; Horne, W.T.; Hontecillas, R.; Bassaganya-Riera, J., 2011:
Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease

Jiang, M-Hua.; Zhu, L.; Jiang, J-Guo., 2011:
Immunoregulatory actions of polysaccharides from Chinese herbal medicine

Zha, X-Qiang.; Zhao, H-Wei.; Bansal, V.; Pan, L-Hua.; Wang, Z-Ming.; Luo, J-Ping., 2014:
Immunoregulatory activities of Dendrobium huoshanense polysaccharides in mouse intestine, spleen and liver

Muller-Haegele, S.; Muller, L.; Whiteside, T.L., 2015:
Immunoregulatory activity of adenosine and its role in human cancer progression

Li, J.; Bao, Y-Xi.; Zhu, X.; Liu, J.; Wang, H-Ping., 2008:
Immunoregulatory activity of polysaccharopeptide and Astragalus polysaccharides on EAC tumor-bearing mice

Dutra, W.O.; de Faria, D.Rodrigues.; Lima Machado, P.Roberto.; Guimarães, L.Henrique.; Schriefer, A.; Carvalho, E.; Gollob, K.J., 2011:
Immunoregulatory and Effector Activities in Human Cutaneous and Mucosal Leishmaniasis: Understanding Mechanisms of Pathology

Jiang, Y.; Ng, T.Bun.; Liu, Z.; Wang, C.; Li, N.; Qiao, W.; Liua, F., 2015:
Immunoregulatory and anti-HIV-1 enzyme activities of antioxidant components from lotus (Nelumbo nucifera Gaertn.) rhizome

Priftis, A.; Angeli-Terzidou, A-Eugenia.; Veskoukis, A.S.; Spandidos, D.A.; Kouretas, D., 2018:
Cell‑specific and roasting‑dependent regulation of the Keap1/Nrf2 pathway by coffee extracts

Chirigos, M.A.; De Simone, C., 1993:
Immunoregulatory biological response modifiers: effect of cytokines on septic shock

Chatten, C.; Bathe, O.F., 2010:
Immunoregulatory cells of the tumor microenvironment

Todorović, M.M.; Zvrko, E.Z., 2014:
Immunoregulatory cytokines and chronic tonsillitis

Robinson, M.W.; O'Brien, R.; Mackintosh, C.G.; Clark, R.G.; Griffin, J.F.T., 2011:
Immunoregulatory cytokines are associated with protection from immunopathology following Mycobacterium avium subspecies paratuberculosis infection in red deer

El Mahgoub, I.R.; Afify, R.A.Aleem.; Botros, S.K.A.; Fawzy, R., 2014:
Immunoregulatory cytokines gene polymorphisms in Egyptian patients affected with acquired aplastic anemia

Canellada, A.; Custidiano, A.; Abraham, F.; Rey, E.; Gentile, T., 2013:
Immunoregulatory cytokines in mouse placental extracts inhibit in vitro osteoclast differentiation of murine macrophages

Karczewski, J.; Karczewski, M., 2013:
Immunoregulatory defect in patients with active Crohn's disease

Trucco, M.; Giannoukakis, N., 2007:
Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus

Giannoukakis, N., 2014:
Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie Lockwood

Luo, X.; Yang, K.; Sun, M., 2011:
Immunoregulatory effect of Huangqi Fuzhengtang on immunosuppressive mice

Vargova, L.; Zacharovova, K.; Dovolilova, E.; Vojtova, L.; Saudek, F., 2014:
Immunoregulatory effect of anti-thymocyte globulin monotherapy on peripheral lymphoid tissues of non-obese diabetic mice

Li, T.; Chen, H.; Liu, X-Guang.; Zhou, Y-Xun.; Bai, S-Fang., 2013:
Immunoregulatory effect of artesunate on allergic contact dermatitis and its mechanism

Tomosada, Y.; Villena, J.; Murata, K.; Chiba, E.; Shimazu, T.; Aso, H.; Iwabuchi, N.; Xiao, J-zhong.; Saito, T.; Kitazawa, H., 2013:
Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression

Sun, Y.; Zhang, F-Shan.; Zhang, Z-Yi., 2008:
Immunoregulatory effect of bone marrow mesenchymal stem cells on regulatory T cells in patients with systemic lupus erythematosis

Hu, H-Yan.; Song, Z-Yang.; Deng, L.; Zhang, M-Xia., 2008:
Immunoregulatory effect of evodiamine in mice of various germlines

Ye, F.; Qiao, Z-Hua.; Zhu, L.; Yang, T.; Yang, L-Hua., 2008:
Immunoregulatory effect of mesenchymal stem cells on active T lymphocytes

Setiyono, A.; Budiyati, A.D.; Purwantomo, S.; Anggelia, M.R.; Fanany, I.; Wibowo, G.A.; Bachtiar, I.; Utama, A.; Tai, S., 2011:
Immunoregulatory effects of AFP domains on monocyte-derived dendritic cell function

Soares, M.P.; Marguti, I.; Cunha, A.; Larsen, R., 2010:
Immunoregulatory effects of HO-1: how does it work?

Yoshino, S.; Yoshimura, K.; Suzuki, N.; Iida, M.; Yoshida, S.; Maeda, Y.; Maeda, K.; Hazama, S.; Oka, M., 2011:
Immunoregulatory effects of PSK on the Th1/Th2 balance and regulatory T-cells in patients with colorectal cancer

Guo, F.; Xue, C.; Wu, C.; Zhao, X.; Qu, T.; He, X.; Guo, Z.; Zhu, R., 2014:
Immunoregulatory effects of Taishan Pinus massoniana pollen polysaccharide on chicks co-infected with avian leukosis virus and Bordetella avium early in ovo

Pezato, Rério.; de Almeida, D.Cândido.; Bezerra, T.Freire.; Silva, F.de.Sá.; Perez-Novo, C.; Gregório, Lís.Carlos.; Voegels, R.Louis.; Câmara, N.Olsen.; Bachert, C., 2014:
Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment

Liu, H.; Li, W.; Gu, W.; Kong, Y.; Yang, N.; Chen, L., 2010:
Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis

Ismail, M.; Morgan, R.; Harrington, K.; Davies, J.; Pandha, H., 2011:
Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model

Ahmadi-Ashtiani, H-Reza.; Allameh, A.; Rastegar, H.; Mortaz, E.; Saraf, Z., 2014:
Immunoregulatory effects of glutathione during mesenchymal stem cell differentiation to hepatocyte-like cells

Demircan, P.Cetinalp.; Sariboyaci, A.Eker.; Unal, Z.Seda.; Gacar, G.; Subasi, C.; Karaoz, E., 2012:
Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems

Pennell, L.M.; Fish, E.N., 2015:
Immunoregulatory effects of interferon-β in suppression of Th17 cells

Cai, Y-Feng.; Wu, D-Pei., 2014:
Immunoregulatory effects of interleukin-17 and Th17 cells in graft-versus-host disease

Karadag, A.S.; Ertugrul, D.T.; Bilgili, S.G.; Takci, Z.; Akin, K.O.; Calka, O., 2012:
Immunoregulatory effects of isotretinoin in patients with acne

Gravante, G.; Sconocchia, G.; Ong, S.Ling.; Dennison, A.R.; Lloyd, D.M., 2008:
Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies

Zhang, J.; Shan, B-En.; Li, Q-Min.; Zhang, C.; Zhao, R-Nian.; Ai, J., 2010:
Immunoregulatory effects of periplocin from Cortex Periplocae in tumor-bearing mice

Du, X-gang.; Dong, X-wei.; Chen, J-qiang.; Xie, Q-min., 2008:
Immunoregulatory effects of pertussis protein on allergic asthma in mouse

Cheng, Y.; Zhang, J.; Hou, W.; Wang, D.; Li, F.; Zhang, Y.; Yuan, F., 2009:
Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis

Yazdanbakhsh, K.; Bao, W.; Zhong, H., 2012:
Immunoregulatory effects of stored red blood cells

Nickel, T.; Hanssen, H.; Sisic, Z.; Pfeiler, S.; Summo, C.; Schmauss, D.; Hoster, E.; Weis, M., 2011:
Immunoregulatory effects of the flavonol quercetin in vitro and in vivo

Li, L.; Jiang, Y-Jun.; Yang, X-Yi.; Liu, Y.; Wang, J-Yu.; Man, C-Xin., 2015:
Immunoregulatory effects on Caco-2 cells and mice of exopolysaccharides isolated from Lactobacillus acidophilus NCFM

Tuncel, T.; Karagoz, B.; Haholu, A.; Ozgun, A.; Emirzeoglu, L.; Bilgi, O.; Kandemir, E.Gokhan., 2014:
Immunoregulatory function of HLA-G in gastric cancer

Le Texier, L.; Thebault, P.; Carvalho-Gaspar, M.; Vignard, V.; Merieau, E.; Usal, C.; Cuturi, M-Cristina.; Wood, K.J.; Chiffoleau, E., 2012:
Immunoregulatory function of IL-27 and TGF-β1 in cardiac allograft transplantation

Kurishima, A.; Inaba, M.; Sakaguchi, Y.; Fukui, T.; Uchida, K.; Nishio, A.; Nomura, S.; Okazaki, K., 2015:
Immunoregulatory function of PIR-A/B+ DCs in the inflammatory responses of dextran sodium sulfate-induced colitis

Li, X-bing.; He, X-juan.; Liu, B.; Xu, L.; Ju, D-hong.; Jiang, M.; Lu, A-ping., 2012:
Immunoregulatory function of Radix Glycyrrhizae polysaccharide in tumor-bearing mice

Matysiak, M.; Orlowski, W.; Fortak-Michalska, M.; Jurewicz, A.; Selmaj, K., 2011:
Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2

Guo, Z-Xing.; Zheng, C-Ling.; Chen, Z-Ping.; Dong, W-Chuan.; Yang, R-Chi., 2012:
Immunoregulatory function of interleukin-6 on human Th17 cells

Zimecki, Mł.; Artym, J.; Chodaczek, G.; Kocieba, M.; Kuryszko, J.; Houszka, M.; Kruzel, M.L., 2007:
Immunoregulatory function of lactoferrin in immunosuppressed and autoimmune animals

Kong, W-Xia.; Jiang, X-Xia.; Mao, N., 2011:
Immunoregulatory function of mesenchymal stem cells and application of mesenchymal stem cells in therapy of autoimmune disease

Ma, M.; Shan, B-En.; Liu, W.; Ai, J.; Liu, L-Hua., 2016:
Immunoregulatory function of rat bone marrow mesenchymal stem cells on spleen mononuclearcell.

Banh, C.; Fugère, Céline.; Brossay, L., 2010:
Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling

Conway, S.E.; Abdi, R., 2010:
Immunoregulatory gene polymorphisms and graft-versus-host disease

Sugita, N.; Kobayashi, T.; Kikuchi, A.; Shimada, Y.; Hirano, E.; Sasahara, J.; Tanaka, K.; Yoshie, H., 2012:
Immunoregulatory gene polymorphisms in Japanese women with preterm births and periodontitis

Gostner, J.; Ciardi, C.; Becker, K.; Fuchs, D.; Sucher, R., 2014:
Immunoregulatory impact of food antioxidants

Gollob, K.J.; Antonelli, L.R.V.; Faria, D.R.; Keesen, T.S.L.; Dutra, W.O., 2008:
Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology

Cheng, J.; Zhang, X-min.; Shen, Z-yin.; Chen, W-hua.; Cai, W-jiao.; Ying, J.; Hu, G-rang.; Liu, R-hong., 2013:
Immunoregulatory mechanisms of an optimal Chinese herbal monomer compound in mice with allergic rhinitis

Mann, E.H.; Chambers, E.S.; Pfeffer, P.E.; Hawrylowicz, C.M., 2014:
Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma

Filippi, C.M.; Estes, E.A.; Oldham, J.E.; von Herrath, M.G., 2009:
Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice

Bassaganya-Riera, J.; Viladomiu, M.; Pedragosa, M.; De Simone, C.; Hontecillas, R., 2012:
Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria

Cao, Y.; Zhang, L.; Ritprajak, P.; Tsushima, F.; Youngnak-Piboonratanakit, P.; Kamimura, Y.; Hashiguchi, M.; Azuma, M., 2011:
Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis

de la Fuente, H.; Cibrián, D.; Sánchez-Madrid, F., 2012:
Immunoregulatory molecules are master regulators of inflammation during the immune response

Hunt, J.S.; Pace, J.L.; Gill, R.M., 2010:
Immunoregulatory molecules in human placentas: potential for diverse roles in pregnancy

Muramoto, K., 2013:
Immunoregulatory molecules reveal crosstalk between immune and pain responses

Altman, A., 1980:
Immunoregulatory networks

Dutra, W.O.; Menezes, C.A.S.; Magalhães, L.M.D.; Gollob, K.J., 2014:
Immunoregulatory networks in human Chagas disease

Levitsky, J.; Miller, J.; Wang, E.; Rosen, A.; Flaa, C.; Abecassis, M.; Mathew, J.; Tambur, A., 2009:
Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents

Chikamatsu, K.; Takahashi, G.; Sakakura, K.; Ferrone, S.; Masuyama, K., 2011:
Immunoregulatory properties of CD44+ cancer stem-like cells in squamous cell carcinoma of the head and neck

Tukaj, S., 2015:
Immunoregulatory properties of Hsp70

Blancou, P.; Tardif, V.; Simon, T.; Rémy, Séverine.; Carreño, L.; Kalergis, A.; Anegon, I., 2011:
Immunoregulatory properties of heme oxygenase-1

Holan, V.; Pokorna, K.; Prochazkova, J.; Krulova, M.; Zajicova, A., 2010:
Immunoregulatory properties of mouse limbal stem cells

Michel-Monigadon, D.; Brachet, P.; Neveu, I.; Naveilhan, P., 2011:
Immunoregulatory properties of neural stem cells

Chan, K.Yuen.Yee.; Leung, F.Wan.Lun.; Lam, H.Simon.; Tam, Y.Him.; To, K.Fai.; Cheung, H.Ming.; Leung, K.Tong.; Poon, T.Chuen.Wai.; Lee, K.Hung.; Li, K.; Fok, T.Fai.; Ng, P.Cheung., 2012:
Immunoregulatory protein profiles of necrotizing enterocolitis versus spontaneous intestinal perforation in preterm infants

Ben Aissa-Fennira, F.; Sassi, A.; Bouguerra, A.; Benammar-Elgaaied, A., 2011:
Immunoregulatory role for a public IgM idiotype in the induction of autoimmune diseases in Mycoplasma pneumoniae infection

Xia, J-Bo.; Wang, C-Zheng.; Ma, J-Xin.; An, X-Jing., 2009:
Immunoregulatory role of 1, 25-dihydroxyvitamin D(3)-treated dendritic cells in allergic airway inflammation

Puddu, P.; Latorre, D.; Valenti, P.; Gessani, S., 2010:
Immunoregulatory role of lactoferrin-lipopolysaccharide interactions

Zubov, D.O., 2008:
Immunoregulatory role of mesenchymal stem cells in bone reparation processes

Ehrhardt, Götz.R.A.; Cooper, M.D., 2011:
Immunoregulatory roles for fc receptor-like molecules

Tassinari, O.W.; Aponte, M.; Caiazzo, R.J.; Liu, B.C-S., 2008:
Immunoregulomics : a serum autoantibody-based platform for transcription factor profiling

Streliaeva, A.V.; Polzikov, V.V.; Shcheglova, T.A.; Gasparian, É.R.; Prokina, E.S.; Sadykov, R.V.; Lazareva, N.B.; Samylina, I.A.; Sadykov, V.M.; Chebyshev, N.V., 2011:
Immunorehabilitation in patients with paecilomycosis-complicated echinococcosis and asthma

Coleman, C.; Hubble, J.; Schwab, J.; Beffy, J-Luc.; Picaut, P.; Morte, C., 2012:
Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA

Gomez, G.G.; Hickey, M.J.; Tritz, R.; Kruse, C.A., 2008:
Immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes: downregulation of multiple proapoptotic factors

Recchiuti, A.; Codagnone, M.; Pierdomenico, A.Maria.; Rossi, C.; Mari, V.Cecilia.; Cianci, E.; Simiele, F.; Gatta, V.; Romano, M., 2014:
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages

Jiang, B.; Jiang, Z-Liang., 2008:
Immunoresonance scattering spectral assay for the determination of antithrombin-III

Liang, A-Hui.; Wang, S-Mei., 2008:
Immunoresonance scattering spectral assay of complement factor 4(C4)

Miyano, A.; Nakayama, M.; Waguri, M.; Fujita, T., 2009:
Immunoresponse to SS-A 52-kDa and 60-kDa proteins in mothers of infants with neonatal lupus erythematosus

Goodman, B.P., 2015:
Immunoresponsive postinfectious autonomic neuropathy

Li, C.; Shen, Y.; Sun, C.; Nihad, C.; Tu, J., 2016:
Immunosafety and chronic toxicity evaluation of monomethoxypoly(ethylene glycol)-b-poly(lactic acid) polymer micelles for paclitaxel delivery

Zhang, Y.; Shi, X-Lei.; Han, B.; Gu, J-Yang.; Chu, X-Hui.; Xiao, J-Qiang.; Ren, H-Zhen.; Tan, J-Jun.; Ding, Y-Tao., 2012:
Immunosafety evaluation of a multilayer flat-plate bioartificial liver

Peña, Yé.; Perera, A.; Batista, J.F., 2015:
Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013)

Dijkers, E.C.F.; de Vries, E.G.E.; Kosterink, J.G.W.; Brouwers, A.H.; Lub-de Hooge, M.N., 2009:
Immunoscintigraphy as potential tool in the clinical evaluation of HER2/neu targeted therapy

Yao, Y-Feng.; Yang, Z.; Li, Z-Fu.; Gu, J., 2007:
Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58

Birchler, M.T.; Thuerl, C.; Schmid, D.; Neri, D.; Waibel, R.; Schubiger, A.; Stoeckli, S.J.; Schmid, S.; Goerres, G.W., 2007:
Immunoscintigraphy of patients with head and neck carcinomas, with an anti-angiogenetic antibody fragment

Musette, P.; Even, J.; Dubertret, L.; Kourilsky, P.; Gachelin, G., 2001:
Immunoscope analysis of T-lymphocytes infiltrating melanocytic tumors

Curigliano, G.; Perez, E.A., 2015:
Immunoscoring breast cancer: TILs remember what they target

Velan, B., 2008:
Immunoscreening after hybrid selection and translation

Duan, X-wei.; Fu, Y-hui.; Lu, Y.; Huang, C-yu.; Ju, C.; Xu, B.; Xu, X-nian.; Feng, Z.; Hu, W., 2010:
Immunoscreening and identification of Schistosoma japonicum juvenile cDNA library

Lu, Y.; Xu, B.; Ju, C.; Mo, X-Jin.; Chen, S-Bo.; Feng, Z.; Wang, X-Ning.; Hu, W., 2013:
Immunoscreening of Schistosoma japonicum egg cDNA library and identification of positive clones

St John, T.P., 2008:
Immunoscreening of fusion proteins produced in lambda plaques

Klein-Scory, S.; Kübler, S.; Diehl, H.; Eilert-Micus, C.; Reinacher-Schick, A.; Stühler, K.; Warscheid, B.; Meyer, H.E.; Schmiegel, W.; Schwarte-Waldhoff, I., 2010:
Immunoscreening of the extracellular proteome of colorectal cancer cells

Chen, L.; Chen, W.; Zhao, L.; Yu, H-Zhen.; Li, X., 2008:
Immunoscreening of urinary bladder cancer cDNA library and identification of potential tumor antigen

McGookin, R., 1988:
Immunoscreening of λgt11 Expression Libraries Using an Avidin-Biotin Detection System

MacLaren, R., 2010:
Immunosedation: a consideration for sepsis

Ghosh, P.; Moore, R.; Vernon-Roberts, B.; Goldschlager, T.; Pascoe, D.; Zannettino, A.; Gronthos, S.; Itescu, S., 2012:
Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs

Reim, F.; Dombrowski, Y.; Ritter, C.; Buttmann, M.; Häusler, S.; Ossadnik, M.; Krockenberger, M.; Beier, D.; Beier, C.P.; Dietl, J.; Becker, Jürgen.C.; Hönig, A.; Wischhusen, Jörg., 2009:
Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells

Pawelec, G., 2014:
Immunosenenescence: role of cytomegalovirus

Reber, A.J.; Chirkova, T.; Kim, J.Hyang.; Cao, W.; Biber, R.; Shay, D.K.; Sambhara, S., 2012:
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population

Pawelec, G.; Akbar, A.; Beverley, P.; Caruso, C.; Derhovanessian, E.; Fülöp, T.; Griffiths, P.; Grubeck-Loebenstein, B.; Hamprecht, K.; Jahn, G.; Kern, F.; Koch, S.D.; Larbi, A.; Maier, A.B.; Macallan, D.; Moss, P.; Samson, S.; Strindhall, J.; Trannoy, E.; Wills, M., 2010:
Immunosenescence and Cytomegalovirus: where do we stand after a decade?

Tsoukas, C., 2015:
Immunosenescence and aging in HIV

Candore, G.; Balistreri, C.Rita.; Colonna-Romano, G.; Grimaldi, M.Paola.; Lio, D.; Listi', F.; Scola, L.; Vasto, S.; Caruso, C., 2008:
Immunosenescence and anti-immunosenescence therapies: the case of probiotics

Fulop, T.; Larbi, A.; Witkowski, J.M.; Kotb, R.; Hirokawa, K.; Pawelec, G., 2014:
Immunosenescence and cancer

Provinciali, M., 2009:
Immunosenescence and cancer vaccines

Minato, N., 2012:
Immunosenescence and diseases: follicular T cell response in germinal center

Lang, P.Olivier.; Aspinall, R., 2012:
Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules?

Martins, P.Ney.Aguiar.; Tullius, S.G.; Markmann, J.F., 2015:
Immunosenescence and immune response in organ transplantation

Ostan, R.; Bucci, L.; Capri, M.; Salvioli, S.; Scurti, M.; Pini, E.; Monti, D.; Franceschi, C., 2008:
Immunosenescence and immunogenetics of human longevity

Crétel, E.; Veen, I.; Pierres, A.; Bongrand, P.; Gavazzi, G., 2010:
Immunosenescence and infections, myth or reality?

Moro-García, M.Antonio.; Echeverría, A.; Galán-Artímez, Mía.Concepción.; Suárez-García, F.Manuel.; Solano-Jaurrieta, J.José.; Avanzas-Fernández, P.; Díaz-Molina, Bíz.; Lambert, J.L.; López-Larrea, C.; Morís de la Tassa, C.; Alonso-Arias, R., 2015:
Immunosenescence and inflammation characterize chronic heart failure patients with more advanced disease

Sambhara, S.; McElhaney, J.E., 2009:
Immunosenescence and influenza vaccine efficacy

Boldizsar, F.; Mikecz, K.; Glant, T.T., 2010:
Immunosenescence and its potential modulation: lessons from mouse models

Mayerl, C.; Prelog, M., 2012:
Immunosenescence and juvenile idiopathic arthritis

Dorrington, M.G.; Bowdish, D.M.E., 2013:
Immunosenescence and novel vaccination strategies for the elderly

Krone, C.L.; van de Groep, K.; Trzciński, K.; Sanders, E.A.M.; Bogaert, D., 2014:
Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions

Roberts, K.E.; Hughes, W.O.H., 2015:
Immunosenescence and resistance to parasite infection in the honey bee, Apis mellifera

Fulop, T.; Pawelec, G.; Castle, S.; Loeb, M., 2009:
Immunosenescence and vaccination in nursing home residents

Ongrádi, J.; Stercz, B.; Kövesdi, Véria.; Vértes, L., 2010:
Immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment

Ongrádi, J.; Stercz, B.; Kövesdi, Véria.; Vértes, L., 2009:
Immunosenescence and vaccination of the elderly, I. Age-related immune impairment

Hutt, H.Joachim.; Bennerscheidt, P.; Thiel, B.; Arand, M., 2011:
Immunosenescence and vaccinations in the elderly

Grubeck-Loebenstein, B.; Della Bella, S.; Iorio, A.Maria.; Michel, J-Pierre.; Pawelec, G.; Solana, R., 2009:
Immunosenescence and vaccine failure in the elderly

Boraschi, D.; Italiani, P., 2015:
Immunosenescence and vaccine failure in the elderly: strategies for improving response

Hock, K.; Oberhuber, R.; Lee, Y-Lung.; Wrba, F.; Wekerle, T.; Tullius, S.G., 2013:
Immunosenescence does not abrogate engraftment of murine allogeneic bone marrow

Linton, P-Jean.; Thoman, M.L., 2015:
Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart

Johnstone, J.; Millar, J.; Lelic, A.; Verschoor, C.P.; Walter, S.D.; Devereaux, P.J.; Bramson, J.; Loeb, M., 2014 :
Immunosenescence in the nursing home elderly

Trzonkowski, P.; Debska-Slizień, A.; Jankowska, M.; Wardowska, A.; Carvalho-Gaspar, M.; Hak, Łukasz.; Moszkowska, G.; Bzoma, B.; Mills, N.; Wood, K.J.; Myśliwska, J.; Rutkowski, Bław., 2010:
Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells

Sidler, C.; Wóycicki, Rł.; Ilnytskyy, Y.; Metz, G.; Kovalchuk, I.; Kovalchuk, O., 2013:
Immunosenescence is associated with altered gene expression and epigenetic regulation in primary and secondary immune organs

Rizzo, L.Bortolotto.; Do Prado, C.Hartmann.; Grassi-Oliveira, R.; Wieck, Aéa.; Correa, B.Luz.; Teixeira, A.Lucio.; Bauer, Més.Evandro., 2014:
Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder

Unemori, P.; Leslie, K.S.; Hunt, P.W.; Sinclair, E.; Epling, L.; Mitsuyasu, R.; Effros, R.B.; Dock, J.; Dollard, S.G.; Deeks, S.G.; Martin, J.N.; Maurer, T.A., 2014:
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection

Gayoso, I.; Sanchez-Correa, B.; Campos, C.; Alonso, C.; Pera, A.; Casado, J.G.; Morgado, S.; Tarazona, R.; Solana, R., 2011:
Immunosenescence of human natural killer cells

Wessels, I.; Jansen, J.; Rink, L.; Uciechowski, P., 2010:
Immunosenescence of polymorphonuclear neutrophils

Montoya-Ortiz, G., 2013:
Immunosenescence, aging, and systemic lupus erythematous

Peters, T., 2012:
Immunosenescence. Current status and molecular mechanisms

Lang, P.Olivier.; Govind, S.; Michel, J.Pierre.; Aspinall, R.; Mitchell, W.A., 2011:
Immunosenescence: Implications for vaccination programmes in adults

Haq, K.; McElhaney, J.E., 2014:
Immunosenescence: Influenza vaccination and the elderly

Su, D-Ming.; Aw, D.; Palmer, D.B., 2013:
Immunosenescence: a product of the environment?

Hakim, F.T.; Gress, R.E., 2005:
Immunosenescence: immune deficits in the elderly and therapeutic strategies to enhance immune competence

McElhaney, J.E.; Effros, R.B., 2009:
Immunosenescence: what does it mean to health outcomes in older adults?

Fernandez, S.; French, M.A.; Price, P., 2012:
Immunosenescent CD57+CD4+ T-cells accumulate and contribute to interferon-γ responses in HIV patients responding stably to ART

Kumamoto, C.A.; Pierce, J.V., 2011:
Immunosensing during colonization by Candida albicans: does it take a village to colonize the intestine?

Wu, Y.; Liu, S., 2009:
Immunosensing system for alpha-fetoprotein through boronate immunoaffinity column in combination with flow injection chemiluminescence

Begley, J.; Vo, D.D.; Morris, L.F.; Bruhn, K.W.; Prins, R.M.; Mok, S.; Koya, R.C.; Garban, H.J.; Comin-Anduix, B.; Craft, N.; Ribas, A., 2008:
Immunosensitization with a Bcl-2 small molecule inhibitor

Wang, D.; Dou, W.; Zhao, G.; Chen, Y., 2015:
Immunosensor based on electrodeposition of gold-nanoparticles and ionic liquid composite for detection of Salmonella pullorum

Ramanavicius, A.; Ryskevic, N.; Oztekin, Y.; Kausaite-Minkstimiene, A.; Jursenas, S.; Baniukevic, J.; Kirlyte, J.; Bubniene, U.; Ramanaviciene, A., 2011:
Immunosensor based on fluorescence quenching matrix of the conducting polymer polypyrrole

Moraes, M.L.; Lima, L.R.; Silva, R.R.; Cavicchioli, M.; Ribeiro, S.J.L., 2013:
Immunosensor based on immobilization of antigenic peptide NS5A-1 from HCV and silk fibroin in nanostructured films

Jang, Y.; Park, J.; Pak, Y.Kim.; Pak, J.Jungho., 2012:
Immunosensor based on the ZnO nanorod networks for the detection of H1N1 swine influenza virus

Wang, T.; Muthuswamy, J., 2008:
Immunosensor for detection of inhibitory neurotransmitter gamma-aminobutyric acid using quartz crystal microbalance

Long, F.; Shi, H-Chang.; Wang, H-Chen.; Sheng, J-Wu., 2015:
Immunosensor for rapid detection of 1,3-dinitrobenzene

Yang, M.; Gong, S., 2010:
Immunosensor for the detection of cancer biomarker based on percolated graphene thin film

Wąsowicz, M.; Milner, Młgorzata.; Radecka, D.; Grzelak, K.; Radecka, H., 2012:
Immunosensor incorporating anti-His (C-term) IgG F(ab') fragments attached to gold nanorods for detection of His-tagged proteins in culture medium

Kim, J-Hoon.; Yeo, W-Hong.; Shu, Z.; Soelberg, S.D.; Inoue, S.; Kalyanasundaram, D.; Ludwig, J.; Furlong, C.E.; Riley, J.J.; Weigel, K.M.; Cangelosi, G.A.; Oh, K.; Lee, K-Hoon.; Gao, D.; Chung, J-Hyun., 2012:
Immunosensor towards low-cost, rapid diagnosis of tuberculosis

Yamaguchi, M.; Matsuda, Y.; Sasaki, S.; Sasaki, M.; Kadoma, Y.; Imai, Y.; Niwa, D.; Shetty, V., 2013:
Immunosensor with fluid control mechanism for salivary cortisol analysis

Kim, D-Min.; Noh, H-Bog.; Park, D.Su.; Ryu, S-Hee.; Koo, J.Seok.; Shim, Y-Bo., 2009:
Immunosensors for detection of Annexin II and MUC5AC for early diagnosis of lung cancer

Kanso, H.; Barthelmebs, L.; Inguimbert, N.; Noguer, T., 2013:
Immunosensors for estradiol and ethinylestradiol based on new synthetic estrogen derivatives: application to wastewater analysis

Zapata, P.; Larraín, C.; Reyes, P.; Fernández, R., 2012:
Immunosensory signalling by carotid body chemoreceptors

Robins, H., 2014:
Immunosequencing: applications of immune repertoire deep sequencing

Ishii, N.; Maeyama, Y.; Karashima, T.; Nakama, T.; Kusuhara, M.; Yasumoto, S.; Hashimoto, T., 2009:
Immunoserological analyses of 55 patients with pemphigus at the Dermatological Department of Kurume University Hospital: an 11-year retrospective study (1996-2006)

Stafford, P.; Cichacz, Z.; Woodbury, N.W.; Johnston, S.Albert., 2014:
Immunosignature system for diagnosis of cancer

Legutki, J.Barten.; Johnston, S.Albert., 2014:
Immunosignatures can predict vaccine efficacy

Hughes, A.K.; Cichacz, Z.; Scheck, A.; Coons, S.W.; Johnston, S.Albert.; Stafford, P., 2013:
Immunosignaturing can detect products from molecular markers in brain cancer

Al-Dubai, H.; Lichtscheidl, I.; Strobl, M.; Pittner, G.; Pittner, F., 2010:
Immunosorbent assay using gold colloid cluster technology for determination of IgEs in patients' sera

Ngotho, M.; Kagira, J.M.; Jensen, H.E.; Karanja, S.M.; Farah, I.O.; Hau, J., 2009:
Immunospecific immunoglobulins and IL-10 as markers for Trypanosoma brucei rhodesiense late stage disease in experimentally infected vervet monkeys

Nieves, W.; Heang, J.; Asakrah, S.; Höner zu Bentrup, K.; Roy, C.J.; Morici, L.A., 2011:
Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization

Linares, Eângela.M.; Pannuti, C.S.; Kubota, L.T.; Thalhammer, S., 2013:
Immunospot assay based on fluorescent nanoparticles for Dengue fever detection

Cubero, J.J.; Lopez, E.; Redondo, P.C.; Alvarado, R.; Pino, G.; Cubero, A.; Martínez, A.; Ferreira, F.; Villa, J.; Martinez, C., 2012:
Immunossupressant and organ transplantation: immunophilins targeting agent and alternative therapies

Weisblat, D.A.; Kuo, D-Han., 2010:
Immunostaining Helobdella (leech) embryos

Nakamura, Y.; Ishigaki, Y., 2014:
Immunostaining and time-lapse analysis of vinblastine-induced paracrystal formation in human A549 cells

Mai, K.T.; Teo, I.; Robertson, S.J.; Marginean, E.Celia.; Islam, S.; Yazdi, H.M., 2010:
Immunostaining as a diagnostic aid in cytopathologic study of upper urinary tract urothelial carcinoma

Agarwal, B.; Ludwig, O.J.; Collins, B.T.; Cortese, C., 2009:
Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma

Sharma, V.P.; DesMarais, V.; Sumners, C.; Shaw, G.; Narang, A., 2008:
Immunostaining evidence for PI(4,5)P2 localization at the leading edge of chemoattractant-stimulated HL-60 cells

Mubarak, M., 2012:
Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford Classification patient cohort

Fernandez-Flores, A., 2010:
Immunostaining for Treponema pallidum: caution in its evaluation

Lant, B.; Derry, W.Brent., 2014:
Immunostaining for markers of apoptosis in the Caenorhabditis elegans germline

Fadhil, W.; Ilyas, M., 2012:
Immunostaining for mismatch repair (MMR) protein expression in colorectal cancer is better and easier to interpret when performed on diagnostic biopsies

Goteri, G.; Zizzi, A.; Sabato, S.; Costagliola, A.; Stramazzotti, D.; Rubini, C.; Discepoli, G.; Capelli, D.; Leoni, P., 2011:
Immunostaining for nucleophosmin in bone marrow trephine biopsy specimens in acute myeloid leukemias

Matsubayashi, Y.; Iwai, L.; Toda, T.; Lu, Q.Richard.; Kawasaki, H., 2009:
Immunostaining for oligodendrocyte-specific galactosphingolipids in fixed brain sections using the cholesterol-selective detergent digitonin

Sasaki, M.; Matsubara, T.; Kakuda, Y.; Sato, Y.; Nakanuma, Y., 2014:
Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma

Alayed, K.M.; Medeiros, L.Jeffrey.; Phan, D.; Ojiaku, C.; Patel, J.; Yap, J.Paul.V.; McCord, Y.; Woods, J.S.; Konoplev, S.; Bueso-Ramos, C.E.; Reyes, S.R., 2013:
Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3

Parekh, A.; Campbell, A.J.M.; Djouhri, L.; Fang, X.; McMullan, S.; Berry, C.; Acosta, C.; Lawson, S.N., 2011:
Immunostaining for the α3 isoform of the Na+/K+-ATPase is selective for functionally identified muscle spindle afferents in vivo

Mackean, M.; Brown, R., 2001:
Immunostaining human paraffin-embedded sections for mismatch repair proteins

El Tal, A.Kader.; Abrou, A.E.; Stiff, M.A.; Mehregan, D.A., 2010:
Immunostaining in Mohs micrographic surgery: a review

Fadhil, W.; Field, J.; Cross, G.; Kaye, P.; Ilyas, M., 2013:
Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!

Haugland, G.Teien.; Pettersen, E.Fausa.; Sviland, C.; Rønneseth, A.; Wergeland, H.I., 2010:
Immunostaining of Atlantic salmon (Salmo salar L.) leucocytes

Murawska, M.; Brehm, A., 2012:
Immunostaining of Drosophila polytene chromosomes to investigate recruitment of chromatin-binding proteins

Becker, L.; Huang, Q.; Mashimo, H., 2008:
Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue

Wang, B-Ju.; Bao, J-Jie.; Wang, J-Zhong.; Wang, Y.; Jiang, M.; Xing, M-You.; Zhang, W-Guang.; Qi, J-Ying.; Roggendorf, M.; Lu, M-Ji.; Yang, D-Liang., 2011:
Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma

Fontanini, G.; Bigini, D.; Vignati, S.; Ribechini, A.; Angeletti, C.; Pingitore, R., 1994:
Immunostaining of cathepsin-d in nonsmall cell lung-cancer - correlations with morphological and biological parameters

Yang, J.; Xu, X., 2012:
Immunostaining of dissected zebrafish embryonic heart

Arvanitis, D.; Kouklis, P.; Demoro, G.; Goutas, N.; Kittas, C.; Szuchet, S., 1995:
Immunostaining of ductal breast carcinomas with the monoclonal-antibody-h

Sentani, K.; Oue, N.; Noguchi, T.; Sakamoto, N.; Matsusaki, K.; Yasui, W., 2010:
Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin

Luo, L.; Chai, P.Chian.; Cai, Y., 2014:
Immunostaining of germline stem cells and the niche in Drosophila ovaries

Tsai, J.H.; Jeng, Y.M.; Pan, C.C.; Lu, S.W.; Kuo, Y.J., 2014:
Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy

Terrenoire, E.; McRonald, F.; Halsall, J.A.; Page, P.; Illingworth, R.S.; Taylor, A.Malcolm.R.; Davison, V.; O'Neill, L.P.; Turner, B.M., 2011:
Immunostaining of modified histones defines high-level features of the human metaphase epigenome

Lu, H.; Rateri, D.L.; Daugherty, A., 2008:
Immunostaining of mouse atherosclerotic lesions

Saito, Y.; Miyasaka, T.; Hatsuta, H.; Takahashi-Niki, K.; Hayashi, K.; Mita, Y.; Kusano-Arai, O.; Iwanari, H.; Ariga, H.; Hamakubo, T.; Yoshida, Y.; Niki, E.; Murayama, S.; Ihara, Y.; Noguchi, N., 2014:
Immunostaining of oxidized DJ-1 in human and mouse brains

Byun, S.Won.; Lee, A.; Kim, S.; Choi, Y.Jin.; Lee, Y.Soo.; Park, J.Sup., 2014:
Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases

Daniels, J.A.; Torbenson, M.; Anders, R.A.; Boitnott, J.K., 2009:
Immunostaining of plasma cells in primary biliary cirrhosis

Steiniger, B.S.; Bubel, S.; Böckler, W.; Lampp, K.; Seiler, A.; Jablonski, B.; Guthe, M.; Stachniss, V., 2014:
Immunostaining of pulpal nerve fibre bundle/arteriole associations in ground serial sections of whole human teeth embedded in technovit® 9100

Taylor, C.P.; Garrido, R., 2008:
Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (alpha2-delta) type 1 protein

Kurth, T.B.; De Bari, C., 2012:
Immunostaining of skeletal tissues

Lai, C-Li.; van den Ham, Ré.; Mol, J.; Teske, E., 2008:
Immunostaining of the androgen receptor and sequence analysis of its DNA-binding domain in canine prostate cancer

Diaper, D.C.; Hirth, F., 2014:
Immunostaining of the developing embryonic and larval Drosophila brain

Nikitina, N.; Bronner-Fraser, M.; Sauka-Spengler, T., 2010:
Immunostaining of whole-mount and sectioned lamprey embryos

Bolzoni Villaret, A.; Schreiber, A.; Facchetti, F.; Fisogni, S.; Lonardi, S.; Lombardi, D.; Cocco, D.; Redaelli de Zinis, L.Oscar.; Nicolai, P., 2010:
Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications

Morton, L.M.; Cerhan, J.R.; Hartge, P.; Vasef, M.A.; Neppalli, V.T.; Natkunam, Y.; Dogan, A.; Dave, B.J.; Jain, S.; Levy, R.; Lossos, I.S.; Cozen, W.; Davis, S.; Schenk, M.Jean.; Maurer, M.J.; Lynch, C.F.; Rothman, N.; Chatterjee, N.; Yu, K.; Staudt, L.M.; Weisenburger, D.D.; Wang, S.S., 2011:
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era

Britto, A.V.; Schenka, Aé.A.; Moraes-Schenka, Nália.G.; Alvarenga, M.; Shinzato, Júlia.Y.; Vassallo, Jé.; Ward, L.S., 2009:
Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer

Maity, B.; Sheff, D.; Fisher, R.A., 2013:
Immunostaining: detection of signaling protein location in tissues, cells and subcellular compartments

Solanki, Y.B.; Jain, S.M., 2011:
Immunostimolatory activities of Vigna mungo L. extract in male Sprague-Dawley rats

Hou, Y.; Ding, X.; Hou, W.; Song, B.; Wang, T.; Wang, F.; Zhong, J., 2013:
Immunostimulant Activity of a Novel Polysaccharide Isolated from Lactarius deliciosus (L. ex Fr.) Gray

Zaveri, M.; Gohil, P.; Jain, S., 2008:
Immunostimulant activity of n-butanol fraction of root bark of Oroxylum indicum, vent

Nayak, S.; Mengi, S., 2010:
Immunostimulant activity of noni (Morinda citrifolia) on T and B lymphocytes

Nassar, S.A.; Mohamed, A.H.; Soufy, H.; Nasr, S.M.; Mahran, K.M., 2012:
Immunostimulant effect of Egyptian propolis in rabbits

Bilen, S.; Bulut, M.; Bilen, Aı.Müge., 2011:
Immunostimulant effects of Cotinus coggyria on rainbow trout (Oncorhynchus mykiss)

Davtyan, H.; Ghochikyan, A.; Hovakimyan, A.; Petrushina, I.; Yu, J.; Flyer, D.; Madsen, P.Juul.; Pedersen, L.Ostergaard.; Cribbs, D.H.; Agadjanyan, M.G., 2014:
Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines

Radhika, P.; Annapurna, A.; Rao, S.Nageswara., 2013 :
Immunostimulant, cerebroprotective & nootropic activities of Andrographis paniculata leaves extract in normal & type 2 diabetic rats

Esposito, S.; Musio, A., 2013:
Immunostimulants and prevention of recurrent respiratory tract infections

Butowski, N., 2009:
Immunostimulants for malignant gliomas

Suomalainen, L-R.; Bandilla, M.; Valtonen, E.T., 2009:
Immunostimulants in prevention of columnaris disease of rainbow trout, Oncorhynchus mykiss (Walbaum)

Won, D.Pil.; Lee, J.Seok.; Kwon, D.Soo.; Lee, K.Eok.; Shin, W.Cheol.; Hong, E.Kee., 2011:
Immunostimulating activity by polysaccharides isolated from fruiting body of Inonotus obliquus

Lee, J.; Kim, S-Lim.; Lee, S.; Chung, M.Ja.; Park, Y.Il., 2015:
Immunostimulating activity of maysin isolated from corn silk in murine RAW 264.7 macrophages

Surinov, B.P.; Isaeva, V.G.; Karpova, N.A., 2014:
Immunostimulating chemosignaling in animals with secondary immunodeficiency

Lehners, N.; Goldschmidt, H.; Raab, M.S., 2012:
Immunostimulating drugs and cytokines

Thisoda, P.; Ketsa-Ard, K.; Thongprasert, S.; Vongsakul, M.; Picha, P.; Karbwang, J.; Na-Bangchang, K., 2013:
Immunostimulating effect of a well-known Thai folkloric remedy in breast cancer patients

Ramírez-León, A.; Barajas-Martinez, Héctor.; Flores-Torales, E.; Orozco-Barocio, A., 2014:
Immunostimulating effect of aqueous extract of Amphypterygium adstringens on immune cellular response in immunosuppressed mice

Lee, J-Bum.; Ohta, Y.; Hayashi, K.; Hayashi, T., 2010:
Immunostimulating effects of a sulfated galactan from Codium fragile

Kim, J-Hoon.; Shin, E-Hye.; Lee, H-Yong.; Lee, B-Gun.; Park, S-Hoon.; Moon, D-In.; Goo, G-Chang.; Kwon, D-Young.; Yang, H-Jeong.; Kim, O-Jin.; Oh, H-Geun., 2014:
Immunostimulating effects of extract of Acanthopanax sessiliflorus

Suguna, P.; Binuramesh, C.; Abirami, P.; Saranya, V.; Poornima, K.; Rajeswari, V.; Shenbagarathai, R., 2014:
Immunostimulation by poly-β hydroxybutyrate-hydroxyvalerate (PHB-HV) from Bacillus thuringiensis in Oreochromis mossambicus

Zaman, M.; Toth, I., 2013:
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships

Daifuku, M.; Yaguchi, Y.; Nishi, K.; Okamoto, T.; Nakano, H.; Nishimoto, S.; Nishikawa, S.; Yamashita, H.; Takimoto, S.; Sugahara, T., 2011:
Immunostimulation effects of yellowtail heart extracts in vitro and in vivo

Wagenlehner, F.M.E.; Ballarini, S.; Naber, K.G., 2015:
Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study

Pugin, Jérôme., 2007:
Immunostimulation is a rational therapeutic strategy in sepsis

Mistrangelo, M.; Cornaglia, S.; Pizzio, M.; Rimonda, R.; Gavello, G.; Dal Conte, I.; Mussa, A., 2011:
Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial

Schefold, J.C., 2012:
Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock

Eggermont, A.M.M., 2010:
Immunostimulation versus immunosuppression after multiple vaccinations: the woes of therapeutic vaccine development

Ha, U-Syn.; Cho, Y-Hyun., 2007:
Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections

Reppe, K.; Tschernig, T.; Lührmann, A.; van Laak, V.; Grote, K.; Zemlin, M.V.; Gutbier, B.; Müller, H.C.; Kursar, M.; Schütte, H.; Rosseau, S.; Pabst, R.; Suttorp, N.; Witzenrath, M., 2008:
Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia

Seki, T.; Kida, K.; Maeda, H., 2008:
Immunostimulation-Mediated Anti-tumor Activity of Bamboo (Sasa senanensis) Leaf Extracts Obtained Under 'Vigorous' Condition

Meng, M.; Li, C.; Wang, Z.; Hua, H.; Shi, J.; Chen, H.; Li, X.; Chen, D., 2013:
Immunostimulator CH2a bearing thiazolidin-4-one promotes the function of human iNKT cells in vitro

Weeratna, R.; Krieg, A.M.; Davis, H.L., 2000:
Immunostimulatory CpG motifs and DNA vaccines

Kant, R.; de Vos, W.M.; Palva, A.; Satokari, R., 2014:
Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease

Olbert, P.J.; Schrader, A.J.; Hofmann, R.; Hegele, A., 2008:
Immunostimulatory CpG oligodeoxynucleotides (CpG-ODN) in an orthotopic murine transitional cell carcinoma (TCC) model. Effect on local cytokine expression

Maurer, T.; Pournaras, C.; Aguilar-Pimentel, J.A.; Thalgott, M.; Horn, T.; Heck, M.; Heit, A.; Kuebler, H.; Gschwend, Jürgen.E.; Nawroth, R., 2014:
Immunostimulatory CpG-DNA and PSA-peptide vaccination elicits profound cytotoxic T cell responses

Higgins, D.; Marshall, J.D.; Traquina, P.; Van Nest, G.; Livingston, B.D., 2007:
Immunostimulatory DNA as a vaccine adjuvant

Van Uden, J.H.; Raz, E., 2000:
Immunostimulatory DNA sequences : an overview

Shin, S.; Kwon, J.; Lee, S.; Kong, H.; Lee, S.; Lee, C-Kil.; Cho, K.; Ha, N-Joo.; Kim, K., 2010:
Immunostimulatory Effects of Cordyceps militaris on Macrophages through the Enhanced Production of Cytokines via the Activation of NF-kappaB

Kim, J-Mi.; Joo, H-Gu., 2012:
Immunostimulatory Effects of β-glucan Purified from Paenibacillus polymyxa JB115 on Mouse Splenocytes

Anz, D.; Koelzer, V.H.; Moder, S.; Thaler, R.; Schwerd, T.; Lahl, K.; Sparwasser, T.; Besch, R.; Poeck, H.; Hornung, V.; Hartmann, G.; Rothenfusser, S.; Bourquin, C.; Endres, S., 2010:
Immunostimulatory RNA blocks suppression by regulatory T cells

Bourquin, C.; Schmidt, L.; Lanz, A-Lisa.; Storch, B.; Wurzenberger, C.; Anz, D.; Sandholzer, N.; Mocikat, R.; Berger, M.; Poeck, H.; Hartmann, G.; Hornung, V.; Endres, S., 2009:
Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7

Degauque, N.; Mariat, C.; Kenny, J.; Zhang, D.; Gao, W.; Vu, M.Diem.; Alexopoulos, S.; Oukka, M.; Umetsu, D.T.; DeKruyff, R.H.; Kuchroo, V.; Zheng, X.Xiao.; Strom, T.B., 2007:
Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice

Philippi, M.Elisa.; Duarte, B.Momm.; Da Silva, C.Vieira.; De Souza, M.Thomaz.; Niero, R.; Cechinel Filho, V.; Bueno, E.Casagranda., 2010:
Immunostimulatory acivity of Calophyllum brasiliense, Ipomoea pes-caprae and Matayba elaeagnoides demonstrated by human peripheral blood mononuclear cells proliferation

Wang, G-Xue.; Liu, Y-Tao.; Li, F-Yuan.; Gao, H-Tao.; Lei, Y.; Liu, X-Lin., 2010:
Immunostimulatory activities of Bacillus simplex DR-834 to carp (Cyprinus carpio)

Wang, G-X.; Li, F-Y.; Cui, J.; Wang, Y.; Liu, Y-T.; Han, J.; Lei, Y., 2011:
Immunostimulatory activities of a decapeptide derived from Alcaligenes faecalis FY-3 to crucian carp

Niu, Y-Cai.; Liu, J-Cheng.; Zhao, X-Mei.; Su, F-Qin.; Cui, H-Xia., 2009:
Immunostimulatory activities of a low molecular weight antitumoral polysaccharide isolated from Agaricus blazei Murill (LMPAB) in Sarcoma 180 ascitic tumor-bearing mice

Yue, G.G.L.; Chan, B.C.L.; Hon, P-Ming.; Kennelly, E.J.; Yeung, S.K.; Cassileth, B.R.; Fung, K-Pui.; Leung, P-Chung.; Lau, C.B.S., 2011:
Immunostimulatory activities of polysaccharide extract isolated from Curcuma longa

Liu, J.; Lei, Y.; Wang, F.; Yi, Y.; Liu, Y.; Wang, G., 2015:
Immunostimulatory activities of specific bacterial secondary metabolite of Anoxybacillus flavithermus strain SX-4 on carp, Cyprinus carpio

Nakano, K.; Kim, D.; Jiang, Z.; Ueno, M.; Okimura, T.; Yamaguchi, K.; Oda, T., 2013:
Immunostimulatory activities of the sulfated polysaccharide ascophyllan from Ascophyllum nodosum in in vivo and in vitro systems

Wang, J.; Yuan, Y.; Yue, T., 2014:
Immunostimulatory activities of β-d-glucan from Ganoderma Lucidum

de Oliveira Silva, Fávio.; das Neves Santos, P.; de Melo, C.Moutinho.Lagos.; Teixeira, E.Holanda.; de Sousa Cavada, B.; Arruda, F.Vassiliepe.Sousa.; Cajazeiras, Jão.Batista.; Almeida, A.Chaves.; Pereira, Véria.Alves.Rêgo.; Porto, A.Lúcia.Figueiredo., 2012:
Immunostimulatory activity of ConBr: a focus on splenocyte proliferation and proliferative cytokine secretion

Benmebarek, A.; Zerizer, S.; Laggoune, S.; Kabouche, Z., 2013:
Immunostimulatory activity of Stachys mialhesi de Noé

Philbin, V.J.; Levy, O., 2007:
Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities

Kim, B.Ra.; Yang, E.Kyoung.; Kim, S.Hee.; Moon, D.Chan.; Kim, H.Jung.; Lee, J.Chul.; Kim, D.Yoon., 2011:
Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma

Palm, N.W.; Medzhitov, R., 2009:
Immunostimulatory activity of haptenated proteins

Choi, J-Ho.; Chung, M.Ja.; Jeong, D-Youn.; Oh, D-Hwan., 2015:
Immunostimulatory activity of isoflavone-glycosides and ethanol extract from a fermented soybean product in human primary immune cells

Bravo-San Pedro, Jé.Manuel.; Senovilla, L., 2014:
Immunostimulatory activity of lifespan-extending agents

Tsukamoto, Y.; Endoh, M.; Mukai, T.; Maeda, Y.; Tamura, T.; Kai, M.; Makino, M., 2011:
Immunostimulatory activity of major membrane protein II from Mycobacterium tuberculosis

Chattopadhyay, U.; Chaudhuri, L.; Ghosal, S., 1986:
Immunostimulatory activity of mangiferin, a naturally occurring xanthone-C-glucoside

Kotzerke, K.; Mempel, M.; Aung, T.; Wulf, G.G.; Urlaub, H.; Wenzel, D.; Schön, M.P.; Braun, A., 2014:
Immunostimulatory activity of murine keratinocyte-derived exosomes

Tincer, G.; Yerlikaya, S.; Yagci, F.C.; Kahraman, T.; Atanur, O.M.; Erbatur, O.; Gursel, I., 2011:
Immunostimulatory activity of polysaccharide-poly(I:C) nanoparticles

Lee, S-Jun.; Rim, H-Kun.; Jung, J-Yun.; An, H-Jin.; Shin, J-Sun.; Cho, C-Won.; Rhee, Y.Kyoung.; Hong, H-Do.; Lee, K-Tae., 2014:
Immunostimulatory activity of polysaccharides from Cheonggukjang

Maeda, R.; Ida, T.; Ihara, H.; Sakamoto, T., 2012:
Immunostimulatory activity of polysaccharides isolated from Caulerpa lentillifera on macrophage cells

Kourelis, A.; Kotzamanidis, C.; Litopoulou-Tzanetaki, E.; Papaconstantinou, J.; Tzanetakis, N.; Yiangou, M., 2011:
Immunostimulatory activity of potential probiotic yeast strains in the dorsal air pouch system and the gut mucosa

Wongprasert, K.; Rudtanatip, T.; Praiboon, J., 2014:
Immunostimulatory activity of sulfated galactans isolated from the red seaweed Gracilaria fisheri and development of resistance against white spot syndrome virus (WSSV) in shrimp

Qiao, D.; Luo, J.; Ke, C.; Sun, Y.; Ye, H.; Zeng, X., 2011:
Immunostimulatory activity of the polysaccharides from Hyriopsis cumingii

Ke, C.; Wang, D.; Sun, Y.; Qiao, D.; Ye, H.; Zeng, X., 2014:
Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid

Faisal, S.M.; Chen, J-wei.; McDonough, S.P.; Chang, C-Fu.; Teng, C-Hao.; Chang, Y-Fu., 2011:
Immunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses

Liu, C-Yan.; Zheng, L.; You, H-Yu.; Zhang, Y.; Wang, J-Xia.; Song, S-Xia., 2008:
Immunostimulatory and antitumor effect of Flt3L and CCL5 on DNA vaccine in DNA prime/protein boost strategy

Lopes, Fávia.C.M.; Calvo, T.R.; Colombo, L.L.; Vilegas, W.; Carlos, I.Z., 2012:
Immunostimulatory and cytotoxic activities of Indigofera suffruticosa (Fabaceae)

Akhtar, M.; Hai, A.; Awais, M.Muhammad.; Iqbal, Z.; Muhammad, F.; ul Haq, A.; Anwar, M.Irfan., 2012:
Immunostimulatory and protective effects of Aloe vera against coccidiosis in industrial broiler chickens

Myschik, J.; Eberhardt, F.; Rades, T.; Hook, S., 2008:
Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part I: Physicochemical characterisation

Myschik, J.; McBurney, W.T.; Hennessy, T.; Phipps-Green, A.; Rades, T.; Hook, S., 2008:
Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part II: In vivo evaluation

Saito, Y.; Higuchi, Y.; Kawakami, S.; Yamashita, F.; Hashida, M., 2008:
Immunostimulatory characteristics induced by linear polyethyleneimine-plasmid DNA complexes in cultured macrophages

Li, I.A.; Popov, A.M.; Tsybul'skiĭ, A.V.; Sanina, N.M.; Kostetskiĭ, E.Ia.; Novikova, O.D.; Portniagina, O.Iu.; Mazeĭka, A.V., 2009:
Immunostimulatory characteristics of a novel carrier on the basis of cucumarioside A2-2 and monogalactosyldiacylgycerol

Wang, Z.; Shen, L.; Wang, J.; Shan, B.; Zhang, L.; Lu, F.; Guo, X.; Li, X., 2013:
Immunostimulatory effect of a composition isolated from white peony root oral liquid in the treatment of radiation-induced esophagitis

Verma, V.Kumar.; Rani, K.Vandana.; Sehgal, N.; Prakash, O., 2014:
Immunostimulatory effect of artificial feed supplemented with indigenous plants on Clarias gariepinus against Aeromonas hydrophila

Pozo-Rubio, T.; Mujico, J.R.; Marcos, A.; Puertollano, E.; Nadal, I.; Sanz, Y.; Nova, E., 2011:
Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formula-fed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system

Park, S-Yong.; Kim, H-Bin.; Kim, J-Hoon.; Lee, J-Mi.; Kim, S-Rae.; Shin, H-Sub.; Yi, T-Hoo., 2014:
Immunostimulatory effect of fermented red ginseng in the mouse model

Staroverov, S.A.; Vidyasheva, I.V.; Gabalov, K.P.; Vasilenko, O.A.; Laskavyi, V.N.; Dykman, L.A., 2012:
Immunostimulatory effect of gold nanoparticles conjugated with transmissible gastroenteritis virus

Lee, J.Young.; Kim, Y-Jin.; Kim, H.Joo.; Kim, Y-Sang.; Park, W., 2012:
Immunostimulatory effect of laminarin on RAW 264.7 mouse macrophages

Rasouli, M.; Karimi, M.Hossein.; Kalani, M.; Ebrahimnezhad, S.; Namayandeh, M.; Moravej, A., 2015:
Immunostimulatory effects of Leishmania infantum HSP70 recombinant protein on dendritic cells in vitro and in vivo

Nudo, L.P.; Catap, E.S., 2011:
Immunostimulatory effects of Uncaria perrottetii (A. Rich.) Merr. (Rubiaceae) vinebark aqueous extract in Balb/C mice

Tang, J.; Cai, J.; Liu, R.; Wang, J.; Lu, Y.; Wu, Z.; Jian, J., 2015:
Immunostimulatory effects of artificial feed supplemented with a Chinese herbal mixture on Oreochromis niloticus against Aeromonas hydrophila

Maghraby, A.S.; Shalaby, N.; Abd-Alla, H.I.; Ahmed, S.A.; Khaled, H.M.; Bahgat, M.M., 2010:
Immunostimulatory effects of extract of Pulicaria crispa before and after Schistosoma mansoni infection

Watanuki, H.; Chakraborty, G.; Korenaga, H.; Kono, T.; Shivappa, R.B.; Sakai, M., 2009:
Immunostimulatory effects of natural human interferon-alpha (huIFN-alpha) on carps Cyprinus carpio L

Cho, C-Won.; Han, C-ji.; Rhee, Y.Kyoung.; Lee, Y-Chul.; Shin, K-Soon.; Hong, H-Do., 2014:
Immunostimulatory effects of polysaccharides isolated from Makgeolli (traditional Korean rice wine)

Yang, E-Jeoung.; Choi, I-Hong., 2013:
Immunostimulatory effects of silica nanoparticles in human monocytes

Cooper, C.L.; Ahluwalia, N.K.; Efler, S.M.; Vollmer, Jörg.; Krieg, A.M.; Davis, H.L., 2008:
Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers

Nishi, K.; Kondo, A.; Okamoto, T.; Nakano, H.; Daifuku, M.; Nishimoto, S.; Ochi, K.; Takaoka, T.; Sugahara, T., 2011:
Immunostimulatory in vitro and in vivo effects of a water-soluble extract from kale

Myschik, J.; McBurney, W.T.; Rades, T.; Hook, S., 2008:
Immunostimulatory lipid implants containing Quil-A and DC-cholesterol

Hasson, T.H.; Takaoka, A.; de la Rica, R.; Matsui, H.; Smeureanu, G.; Drain, C.M.; Kawamura, A., 2015:
Immunostimulatory lipid nanoparticles from herbal medicine

Stewart, C.R.; Karpala, A.J.; Lowther, S.; Lowenthal, J.W.; Bean, A.G., 2011:
Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1

Bodera, P., 2011:
Immunostimulatory oligonucleotides

Tao, Y.; Ju, E.; Ren, J.; Qu, X., 2015:
Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy

Jurk, M.; Chikh, G.; Schulte, B.; Kritzler, A.; Richardt-Pargmann, D.; Lampron, C.; Luu, R.; Krieg, A.M.; Vicari, A.P.; Vollmer, Jörg., 2011:
Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif

Vannucci, L.; Krizan, J.; Sima, P.; Stakheev, D.; Caja, F.; Rajsiglova, L.; Horak, V.; Saieh, M., 2014:
Immunostimulatory properties and antitumor activities of glucans (Review)

Liu, Y.; Jiao, F.; Qiu, Y.; Li, W.; Qu, Y.; Tian, C.; Li, Y.; Bai, R.; Lao, F.; Zhao, Y.; Chai, Z.; Chen, C., 2009:
Immunostimulatory properties and enhanced TNF- alpha mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles

Mallick, S.K.; Maiti, S.; Bhutia, S.K.; Maiti, T.K., 2010:
Immunostimulatory properties of a polysaccharide isolated from Astraeus hygrometricus

Simões, J.; Madureira, P.; Nunes, F.M.; Domingues, M.do.Rosário.; Vilanova, M.; Coimbra, M.A., 2009:
Immunostimulatory properties of coffee mannans

Donaghy, L.; Cabillic, F.; Corlu, A.; Rostan, O.; Toutirais, O.; Guguen-Guillouzo, C.; Guiguen, C.; Gangneux, J-Pierre., 2010:
Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment

Zhou, F.; Song, S.; Chen, W.R.; Xing, D., 2011:
Immunostimulatory properties of glycated chitosan

Wrotek, S.; Skawiński, R.; Kozak, Wław., 2015:
Immunostimulatory properties of mistletoe extracts and their application in oncology

Aranha, I.; Clement, F.; Venkatesh, Y.P., 2012:
Immunostimulatory properties of the major protein from the stem of the Ayurvedic medicinal herb, guduchi (Tinospora cordifolia)

Mendes, R.Gabriela.Pedrosa.Ribeiro.; Gusmão, Mélia.Antônia.do.Nascimento.; Maia, A.Carolina.Ribeiro.Gomes.; Detoni, M.de.Lima.; Porcino, G.Nascimento.; Soares, T.Vieira.; Juliano, M.Aparecida.; Juliano, L.; Coelho, P.Marcos.Zech.; Lenzi, H.Leonel.; Faria-Pinto, P.; Vasconcelos, E.Gomes., 2012:
Immunostimulatory property of a synthetic peptide belonging to the soluble ATP diphosphohydrolase isoform (SmATPDase 2) and immunolocalisation of this protein in the Schistosoma mansoni egg

Verma, V.Kumar.; Rani, K.Vandana.; Sehgal, N.; Prakash, O., 2012:
Immunostimulatory response induced by supplementation of Ficus benghalensis root powder, in the artificial feed the Indian freshwater murrel, Channa punctatus

Ngure, P.; Ng'ang'a, Z.; Kimutai, A.; Kepha, S.; Mong'are, S.; Ingonga, J.; Tonui, W., 2014:
Immunostimulatory responses to crude extracts of Warburgia ugandensis (Sprague) subsp ugandensis (Canellaceae) by BALB/c mice infected with Leishmania major

Wang, G.; Fyhrquist-Vanni, N.; Wolff, H.; Dieu-Nosjean, M-Caroline.; Kemeny, L.; Homey, B.; Lauerma, A.I.; Alenius, H., 2008:
Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model

Won, T-Bin.; Quan, S-Hua.; Kim, D-Young.; Rhee, C-Seo.; Lee, C.Hee., 2009:
Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis

Blanks, D.A., 2007:
Immunostimulatory sequences in immunotherapy

Intra, J.; Zhang, X-Qing.; Williams, R.L.; Zhu, X.; Sandler, A.D.; Salem, A.K., 2011:
Immunostimulatory sutures that treat local disease recurrence following primary tumor resection

Yonemitsu, Y.; Ueda, Y.; Kinoh, H.; Hasegawa, M., 2007:
Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen

Palfrey, S.M., 1999:
Immunosubtraction as a means of typing monoclonal and other proteins in serum and urine

Fülöp, T.; Larbi, A.; Hirokawa, K.; Mocchegiani, E.; Lesourds, B.; Castle, S.; Wikby, A.; Franceschi, C.; Pawelec, G., 2007:
Immunosupportive therapies in aging

Miranda Limón, J.M.; Mendoza, L.; Saavedra, M.A., 2006:
Immunosuppresive treatment in patients with lupus glomerulonephritis. Review of adverse events

Jeon, S-Hee.; Kim, S-Jin.; Kim, J-Shang.; Kang, H-Sub., 2008:
Immunosuppressant FK506 decreases the intracellular magnesium in the human osteoblast cell by inhibiting the ERK1/2 pathway

Saganová, K.; Gálik, Ján.; Blaško, J.; Korimová, A.; Račeková, E.; Vanický, I., 2012:
Immunosuppressant FK506: focusing on neuroprotective effects following brain and spinal cord injury

Gordon, P.A.; Winer, J.B.; Hoogendijk, J.E.; Choy, E.H.S., 2012:
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

Umapathi, T.; Hughes, R.A.C.; Nobile-Orazio, E.; Léger, J-Marc., 2009:
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

Umapathi, T.; Hughes, R.A.C.; Nobile-Orazio, E.; Léger, J-Marc., 2012:
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy

Furusawa, K.; Hasegawa, T.; Ikeda, S., 2013:
Immunosuppressant and infliximab-resistant generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis

Katz, M.E.; Simonetta, S.H.; Ralph, M.R.; Golombek, D.A., 2008:
Immunosuppressant calcineurin inhibitors phase shift circadian rhythms and inhibit circadian responses to light

Louis, E., 2010:
Immunosuppressant combined with infliximab in Crohn's Disease: for 6 months, for 2 years, or forever?

Gabryel, Bżena.; Bielecka, A.; Bernacki, J.; Łabuzek, K.; Herman, Z.S., 2011:
Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivation

Shih, C-Jen.; Tarng, D-Cherng.; Yang, W-Chang.; Yang, C-Yu., 2015:
Immunosuppressant dose reduction and long-term rejection risk in renal transplant recipients with severe bacterial pneumonia

Hart, I.K.; Sharshar, T.; Sathasivam, S., 2009:
Immunosuppressant drugs for myasthenia gravis

Al-Mohammed, H.I., 2010:
Immunosuppressant effects of Leishmania infection in Psammomys obesus trapped in Saudi Arabia

Klawitter, J.; Gottschalk, S.; Hainz, C.; Leibfritz, D.; Christians, U.; Serkova, N.J., 2010:
Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism

Kung, M.; Koschwanez, H.E.; Painter, L.; Honeyman, V.; Broadbent, E., 2012:
Immunosuppressant nonadherence in heart, liver, and lung transplant patients: associations with medication beliefs and illness perceptions

Frassetto, L.A.; Browne, M.; Cheng, A.; Wolfe, A.R.; Roland, M.E.; Stock, P.G.; Carlson, L.; Benet, L.Z., 2007:
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients

Caneguim, B.H.; Cerri, P.S.; Spolidório, Lís.C.; Miraglia, S.M.; Sasso-Cerri, E., 2012:
Immunosuppressant prograf® (tacrolimus) induces histopathological disorders in the peritubular tissue of rat testes

Principi, M.; Ierardi, E.; Antonicelli, D.; Pastorelli, A.; Pisani, A.; Di Leo, A.; Panella, C.; Francavilla, A., 2008:
Immunosuppressant supplementation to infliximab in Crohn's disease with extraintestinal involvement: a benefit in the long term?

Marinova, M.; Artusi, C.; Brugnolo, L.; Antonelli, G.; Zaninotto, M.; Plebani, M., 2014:
Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples

Chisholm-Burns, M.A.; Spivey, C.A.; Rehfeld, R.; Zawaideh, M.; Roe, D.J.; Gruessner, R., 2009:
Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients

Danieli, M.Giovanna.; Spalletta, C.; Moretti, R.; Calabrese, V.; Marchetti, A.; Gabrielli, A.; Logullo, F., 2010:
Immunosuppressant treatment in refractory myositis. Our experience

Bourgeois, J.A.; Hategan, A., 2014:
Immunosuppressant-associated neurotoxicity responding to olanzapine

Mackesy, M.M.; Selhorst, C.; Raza, S., 2015:
Immunosuppressant-induced acneiform eruption of the breast

Mathew, R.; Huang, J.; Katta, U.S.; Krishnan, U.; Sandoval, C.; Gewitz, M.H., 2011:
Immunosuppressant-induced endothelial damage and pulmonary arterial hypertension

Li, H.; He, J-wen.; Fu, B-sheng.; Wang, K.; Jiang, N.; Wang, G-ying.; Zhang, J.; Wang, G-shu.; Yang, Y.; Chen, G-hua., 2013:
Immunosuppressant-related hip pain after orthotopic liver transplant

Püschel, A.; Lindenblatt, N.; Katzfuss, J.; Vollmar, B.; Klar, E., 2012:
Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation

Sontag, C.J.; Nguyen, H.X.; Kamei, N.; Uchida, N.; Anderson, A.J.; Cummings, B.J., 2013:
Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury

Zalpuri, S.; Evers, D.; Zwaginga, J.Jan.; Schonewille, H.; de Vooght, K.M.K.; le Cessie, S.; van der Bom, J.G., 2014:
Immunosuppressants and alloimmunization against red blood cell transfusions

Elefant, E.; Cournot, M-Pierre.; Assari, Fïza.; Vauzelle, C., 2008:
Immunosuppressants for auto-immune diseases and pregnancy

Blagosklonny, M.V., 2014:
Immunosuppressants in cancer prevention and therapy

Hu, P-jin., 2010:
Immunosuppressants in the treatment of inflammatory bowel disease

Pal, Z.; Tóthfalusi, László.; Lörincz, Z.; György, B.; Molnar, M.Judit.; Falus, A.; Buzás, E.I., 2015:
Immunosuppressants increase the levels of natural autoantibodies reactive with glycosaminoglycans in myasthenia gravis

Anonymous, 2009:
Immunosuppressants: JC virus encephalopathy. Rare but fatal

Dell-Olio, D.; Kelly, D.A., 2011:
Immunosuppressants: what's new?

Cordero, E.; Aydillo, T.; Fariñas, M.C.; Paño-Pardo, J.R.; Pachón, J.; Viasus, D.; Riera, M.; López-Medrano, F.; Payeras, A.; Moreno, A.; Rodríguez-Baño, J.; Oteo, J.A.; Martínez-Montauti, J.; Torre-Cisneros, J.; Segura, F.; Carratalá, J.; García-Cabrera, E.; González-Fernández, Jé.Luis.; Gutiérrez-Cuadra, M.; Sanjuan, Mía.Victoria.; Parra, Jé.Antonio.; Martín-Quirós, A.; Romero-Gómez, Mía.; Ruíz-Carrascoso, G.; Figueira, J.Carlos.; Prados, Mía.Concepción.; Niubo, J.; Campi, 2012:
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection

Stine, J.G.; Shah, N.; Argo, C., 2014:
Immunosuppressed solid organ transplant recipient

Colmenero, J.de.Dios.; Castón, J.José.; Torre-Cisneros, Ján., 2009:
Immunosuppressed woman with fever, dyspnea and pulmonary infiltrates

Geissler, E.K., 2010:
Immunosuppression

Derek, E.; Dhanireddy, K., 2013:
Immunosuppression

Schneidewind, A.; Fleck, M.; Salzberger, B.; Schölmerich, J.; Ehrenstein, B., 2009:
Immunosuppression - too strong or too weak?

Todo, S.; Makowka, L.; Starzl, T., 1987:
Immunosuppression with Fr 900506 for Canine Kidney and Liver Transplantation

Marques, R.M.; Teixeira, L.; Aguas, A.P.; Ribeiro, J.C.; Costa-e-Silva, Aónio.; Ferreira, P.G., 2014:
Immunosuppression abrogates resistance of young rabbits to Rabbit Haemorrhagic Disease (RHD)

Kosmidis, M.; Dziunycz, P.; Suárez-Fariñas, M.; Mühleisen, B.; Schärer, L.; Läuchli, S.; Hafner, Jürg.; French, L.E.; Schmidt-Weber, C.; Carucci, J.A.; Hofbauer, Günther.F.L., 2010:
Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients

Wendler, O.; Schäfers, H.J., 2009:
Immunosuppression after heart and lung transplantation

Kihm, L.P.; Zeier, M.; Morath, C., 2011:
Immunosuppression after kidney transplantation

Trunečka, P., 2015:
Immunosuppression after liver transplant, now and in future

Calmus, Y., 2009:
Immunosuppression after liver transplantation

Bayliss, G.P.; Gohh, R.Y.; Morrissey, P.E.; Rodrigue, J.R.; Mandelbrot, D.A., 2014:
Immunosuppression after renal allograft failure: a survey of US practices

Hailer, N.P., 2008:
Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells

Seehafer, S.S.; Ramirez-Montealegre, D.; Wong, A.Ms.; Chan, C-Hung.; Castaneda, J.; Horak, M.; Ahmadi, S.M.; Lim, M.J.; Cooper, J.D.; Pearce, D.A., 2011:
Immunosuppression alters disease severity in juvenile Batten disease mice

Harte, D.; Dosekun, O.; Sethi, G.; Chadborn, T.; de Ruiter, A.; Copas, A.; Edwards, S.G.; Miller, R.F., 2010:
Immunosuppression among HIV-1-positive patients attending for care: experience from two large HIV centres in the United Kingdom

Pinazo, Mía-Jesús.; Espinosa, G.; Cortes-Lletget, C.; Posada, E.de.Jesús.; Aldasoro, E.; Oliveira, Iés.; Muñoz, J.; Gállego, M.; Gascon, J., 2013:
Immunosuppression and Chagas disease: a management challenge

Penn, I.; Starzl, T.E., 1972:
Immunosuppression and Neoplasia

Snell, G.I.; Westall, G.P.; Paraskeva, M.A., 2014:
Immunosuppression and allograft rejection following lung transplantation: evidence to date

Sillaber, C.; Herrmann, H.; Bennett, K.; Rix, U.; Baumgartner, C.; Böhm, A.; Herndlhofer, S.; Tschachler, E.; Superti-Furga, G.; Jäger, U.; Valent, P., 2010:
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily

Baran, D.A.; Taylor, D.O.; Kobashigawa, J.A., 2010:
Immunosuppression and heart transplantation: how do we define success?

von Boehmer, L.; Draenert, A.; Jungraithmayr, W.; Inci, I.; Niklaus, Säfer.; Boehler, A.; Hofer, M.; Stahel, R.; Soltermann, A.; van den Broek, M.; Weder, W.; Knuth, A., 2012:
Immunosuppression and lung cancer of donor origin after bilateral lung transplantation

Zattra, E.; Fortina, A.Belloni.; Bordignon, M.; Piaserico, S.; Alaibac, M., 2009:
Immunosuppression and melanocyte proliferation

Ménard, Cédric.; Tarte, K., 2011:
Immunosuppression and mesenchymal stem cells: back to the future

Lo, A., 2008:
Immunosuppression and metabolic syndrome in renal transplant recipients

Schneeberger, S.; Khalifian, S.; Brandacher, G., 2014:
Immunosuppression and monitoring of rejection in hand transplantation

Rogacev, K.S.; Zawada, A.M.; Hundsdorfer, J.; Achenbach, M.; Held, G.; Fliser, D.; Heine, G.H., 2015:
Immunosuppression and monocyte subsets

Cremer, O.L.; Herold, I.H.F.; Slooter, A.J.C., 2007:
Immunosuppression and multidrug-resistant bacteria in the intensive care unit: a cohort study

van Leeuwen, M.T.; Grulich, A.E.; Webster, A.C.; McCredie, M.R.E.; Stewart, J.H.; McDonald, S.P.; Amin, J.; Kaldor, J.M.; Chapman, J.R.; Vajdic, C.M., 2009:
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation

van Leeuwen, M.T.; Grulich, A.E.; McDonald, S.P.; McCredie, M.R.E.; Amin, J.; Stewart, J.H.; Webster, A.C.; Chapman, J.R.; Vajdic, C.M., 2009:
Immunosuppression and other risk factors for lip cancer after kidney transplantation

Dhouib, I.Bini.; Lasram, M.Montassar.; Abdeladhim, M.; Gharbi, N.; Ahmed, M.Ben.; El-Fazaa, S., 2015:
Immunosuppression and oxidative stress induced by subchronic exposure to carbosulfan in rat spleen: immunomodulatory and antioxidant role of N-acetylcysteine

Schneeberger, S.; Gorantla, V.S.; Hautz, T.; Pulikkottil, B.; Margreiter, R.; Lee, W.P.A., 2009:
Immunosuppression and rejection in human hand transplantation

Büscher, A.K.; Kranz, B.; Büscher, R.; Hildebrandt, F.; Dworniczak, B.; Pennekamp, P.; Kuwertz-Bröking, E.; Wingen, A-Margret.; John, U.; Kemper, M.; Monnens, L.; Hoyer, P.F.; Weber, S.; Konrad, M., 2011:
Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome

Dugué, P-Antoine.; Rebolj, M.; Garred, P.; Lynge, E., 2013:
Immunosuppression and risk of cervical cancer

Landis, M.N.; Davis, C.L.; Bellus, G.A.; Wolverton, S.E., 2011:
Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy

Herman, S.; Rogers, H.D.; Ratner, Désirée., 2007:
Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients

Lindeman, J.H.N.; Rabelink, T.J.; van Bockel, J.Hajo., 2013:
Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde?

Li, J-Ping.; Yang, J.; Huang, J-Ren.; Jiang, D-Lin.; Zhang, F.; Liu, M-Feng.; Qiang, Y.; Gu, Y-Long., 2014:
Immunosuppression and the infection caused by gut mucosal barrier dysfunction in patients with early severe acute pancreatitis

Schütte, D.; Pluschke, G., 2009:
Immunosuppression and treatment-associated inflammatory response in patients with Mycobacterium ulcerans infection (Buruli ulcer)

Gaumann, A.; Schlitt, H.J.; Geissler, E.K., 2007:
Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin

Urschel, S.; Altamirano-Diaz, L.A.; West, L.J., 2010:
Immunosuppression armamentarium in 2010: mechanistic and clinical considerations

Katz, D.R., 1984:
Immunosuppression as a physiological homeostatic mechanism

Gina, M.; Schliemann, S.; Elsner, P., 2016:
Immunosuppression as a possible cofactor of occupational skin cancer in an outdoor worker

Sliwa, K.; Ansari, A.A., 2008:
Immunosuppression as therapy for congestive heart failure

Wiersinga, W.Joost.; van't Veer, C.; van den Pangaart, P.S.; Dondorp, A.M.; Day, N.P.; Peacock, S.J.; van der Poll, T., 2009:
Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis)

Morrison, V.A., 2015:
Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies

Kiselev, O.I., 2013 :
Immunosuppression at pregnancy and flu

Bilbao, I.; Dopazo, C.; Castells, L.; Lazaro, J.; Caralt, M.; Sapisochin, G.; Charco, R., 2015:
Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity

Kahlfuß, S.; Simma, N.; Mankiewicz, J.; Bose, T.; Lowinus, T.; Klein-Hessling, S.; Sprengel, R.; Schraven, B.; Heine, M.; Bommhardt, U., 2014:
Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells

Ghannam, S.; Bouffi, C.; Djouad, F.; Jorgensen, C.; Noël, Dèle., 2010:
Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Ablin, R.J.; Bartkus, J.M.; Gonder, M.J., 1985:
Immunosuppression by seminal plasma

James, K.; Hargreave, T.B., 1984:
Immunosuppression by seminal plasma and its possible clinical significance

Witkin, S.S., 1986:
Immunosuppression by seminal plasma in vitro-an artefact?

Zhu, X.; McTiernan, C.F.; Rajagopalan, N.; Shah, H.; Fischer, D.; Toyoda, Y.; Letts, D.; Bortinger, J.; Gibson, G.; Xiang, W.; McCurry, K.; Mathier, M.; Glorioso, J.C.; London, B., 2012:
Immunosuppression decreases inflammation and increases AAV6-hSERCA2a-mediated SERCA2a expression

Pischiutta, F.; D'Amico, G.; Dander, E.; Biondi, A.; Biagi, E.; Citerio, G.; De Simoni, M.Grazia.; Zanier, E.R., 2014:
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain

Anonymous, 2013:
Immunosuppression due to lymphoma, organ transplant increases risk of melanoma

Luo, L.; Lu, D., 2015:
Immunosuppression during Rhizobium-legume symbiosis

Díaz-San Segundo, F.; Rodríguez-Calvo, T.; de Avila, A.; Sevilla, Ní., 2009:
Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10

Lin, F.; Gao, C.; Chen, S.; Zhu, X.; Cheng, X.; Wang, S.; Chen, S.; Cai, X.; Li, Z.; Ma, C.; Zhao, J., 2012:
Immunosuppression effect of co-infection with MDRV and H9 AIV on thymus in muscovy ducks

Liu, Y-Li.; Wang, Y-Deng.; Zhuang, F.; Xian, S-Li.; Fang, J-Yan.; Su, W.; Zhang, W., 2012:
Immunosuppression effects of bone marrow mesenchymal stem cells on renal interstitial injury in rats with unilateral ureteral obstruction

Prado e Silva, M.; Soto, Sônia.F.; Almeida, F.M.; Limonete, T.T.K.; Parra, E.R.C.; Jatene, F.B.; Pêgo-Fernandes, P.M.; Pazetti, R., 2013:
Immunosuppression effects on airway mucociliary clearance: comparison between two triple therapies

Maglennon, G.A.; McIntosh, P.B.; Doorbar, J., 2014:
Immunosuppression facilitates the reactivation of latent papillomavirus infections

Teebken, O.E.; Bisdas, T., 2011:
Immunosuppression following fresh arterial homograft implantation for aortic graft infections

Chang, D.H.; Kittleson, M.M.; Kobashigawa, J.A., 2014:
Immunosuppression following heart transplantation: prospects and challenges

Kimura, F.; Shimizu, H.; Yoshidome, H.; Ohtsuka, M.; Miyazaki, M., 2011:
Immunosuppression following surgical and traumatic injury

Muñoz-Galdeano, T.; Reigada, D.; Del Águila, Ángela.; Velez, I.; Caballero-López, M.J.; Maza, R.M.; Nieto-Díaz, M., 2018:
Cell Specific Changes of Autophagy in a Mouse Model of Contusive Spinal Cord Injury

Yan, C.; Xu, L.; Liu, D.; Chen, H.; Wang, Y.; Liu, K.; Huang, X., 2015:
Immunosuppression for 6-8 weeks after modified donor lymphocyte infusion reduced acute graft-versus-host disease without influencing graft-versus-leukemia effect in haploidentical transplant

Jampol, L.M.; Fishman, G.A., 2009:
Immunosuppression for autoimmune retinopathy

Cappelli, S.; Guiducci, S.; Bellando Randone, S.; Matucci Cerinic, M., 2014:
Immunosuppression for interstitial lung disease in systemic sclerosis

Hudson, M.; Steele, R.; Baron, M., 2012:
Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational research

Geissler, E.K.; Schlitt, H.J., 2008:
Immunosuppression for liver transplantation

Pascual Santos, J.; Hernández Marrero, D., 2011:
Immunosuppression for living donor renal allograft recipients

Bhorade, S.M.; Stern, E., 2009:
Immunosuppression for lung transplantation

Snell, G.I.; Westall, G.P., 2007:
Immunosuppression for lung transplantation: evidence to date

Gödel, M.; Huber, T.B., 2013:
Immunosuppression for membranous nephropathy

Dhaun, N.; Kluth, D.C., 2013:
Immunosuppression for membranous nephropathy

Chen, Y.; Schieppati, A.; Cai, G.; Chen, X.; Zamora, J.; Giuliano, G.A.; Braun, N.; Perna, A., 2013:
Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

Sloand, E.M.; Barrett, A.J., 2010:
Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success

Stratta, R.J.; Farney, A.C.; Rogers, J.; Orlando, G., 2014:
Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective

Palmares, J.; Castro-Correia, J.; Coutinho, M.F.; Araújo, D.; Delgado, L., 1995:
Immunosuppression in Behçet's disease Clinical management and long-term visual outcome

Boillot, O.; Dumortier, Jérôme., 2007:
Immunosuppression in HCV-positive liver transplant recipients: Pandora's box?

Chan, A.James.; Lake, J.R., 2013:
Immunosuppression in HCV-positive liver-transplant recipients

Seetharam, A.; Perrillo, R.; Gish, R., 2014:
Immunosuppression in Patients with Chronic Hepatitis B

Madani, H.; Hettiaratchy, S.; Clarke, A.; Butler, P.E.M., 2007:
Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation

Bedoya, A.M.; Tate, D.J.; Baena, A.; Córdoba, C.M.; Borrero, M.; Pareja, Ré.; Rojas, F.; Patterson, J.R.; Herrero, R.; Zea, A.H.; Sanchez, G.I., 2014:
Immunosuppression in cervical cancer with special reference to arginase activity

Chan, A.; Stüve, O.; von Ahsen, N., 2009:
Immunosuppression in clinical practice: approaches to individualized therapy

Sereda, A.D.; Nogina, I.V., 2012:
Immunosuppression in dogs and pigs infected with canine distemper virus

Manuel, O.; Baid-Agrawal, S.; Moradpour, D.; Pascual, M., 2012:
Immunosuppression in hepatitis C virus-infected patients after kidney transplantation

Rhee, J.; Al-Mana, N.; Freeman, R., 2010:
Immunosuppression in high-risk transplantation

Cohen, B.L.; Torres, J.; Colombel, J-Frédéric., 2012:
Immunosuppression in inflammatory bowel disease: how much is too much?

Van Assche, G.; Vermeire, Séverine.; Rutgeerts, P., 2009:
Immunosuppression in inflammatory bowel disease: traditional, biological or both?

Cicora, F.; Roberti, J.; Lausada, N.; González, P.; Guerrieri, D.; Stringa, P.; Raimondi, C., 2012:
Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression

Legendre, C.; Zuber, J.; Anglicheau, D.; Le Quintrec, M.; Martinez, F.; Mamzer-Bruneel, M.F.; Thervet, E., 2008:
Immunosuppression in kidney transplantation

Balssa, L.; Bittard, H.; Kleinclauss, F.; Badet, L.; Barbet, S.; Barrou, B.; Benoit, G.; Blanchet, P.; Boutin, J-M.; Delaporte, V.; Dugardin, F.; Ferhi, K.; Feuillu, B.; Gigante, M.; Hubert, J.; Karam, G.; Kleinclauss, F.; Mongiat-Arthus, P.; Neuzillet, Y.; Petit, J.; Sallusto, F.; Salomon, L.; Tariel, E.; Terrier, N.; Thillou, X.; Thuret, R.; Timsit, M-O., 2011:
Immunosuppression in kidney transplantation

Duvoux, C.; Pageaux, G.P., 2011:
Immunosuppression in liver transplant recipients with renal impairment

Serrano Aulló, M.Trinidad.; Parra Moncasi, E.; Lorente Pérez, S., 2011:
Immunosuppression in liver transplantation: renoprotective regimens

Scheffert, J.L.; Raza, K., 2014:
Immunosuppression in lung transplantation

Wüthrich, R.P., 2009:
Immunosuppression in membranous glomerulonephritis - contra

Stahl, R.A.K., 2009:
Immunosuppression in membranous glomerulonephritis - pro

Malaise, J.; De Roover, A.; Squifflet, J.P.; Land, W.; Neuhaus, P.; Pratschke, J.; Kahl, A.; Pascher, A.; Boas-Knoop, S.; Arbogast, H.; Hoffmann, J.; Illner, W.D.; Seissler; Schlamp; Viebahn; Wunsch; Hajt; Klar, E.; Scharek, W.; Hopt; Pisarski, P.; Drognitz, O.; Thurow, C.; Dette, K.; Bechstein, W.O.; Woeste, G.; Klempnauer, J.; Becker, T.; Lück; Neipp; Königsrainer, A.; Steurer, W.; Margreiter, R.; Mark; Bonatti; Saudek, F.; Boucek, P.; Adamec, M.; Havrdova, T.; Koznarova, R.; Vanrenterghem,, 2009:
Immunosuppression in pancreas transplantation: the Euro SPK trials and beyond

Boomer, J.S.; To, K.; Chang, K.C.; Takasu, O.; Osborne, D.F.; Walton, A.H.; Bricker, T.L.; Jarman, S.D.; Kreisel, D.; Krupnick, A.S.; Srivastava, A.; Swanson, P.E.; Green, J.M.; Hotchkiss, R.S., 2011:
Immunosuppression in patients who die of sepsis and multiple organ failure

Dasari, B.V.M.; McBrearty, A.; Gardiner, K., 2012:
Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma

Grossman, S.A.; Ye, X.; Lesser, G.; Sloan, A.; Carraway, H.; Desideri, S.; Piantadosi, S., 2012:
Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide

Dhawan, A., 2012:
Immunosuppression in pediatric liver transplantation: are little people different?

De Giorgi, A.; Fabbian, F., 2014:
Immunosuppression in renal transplantation and dyslipidemia, which factors should be considered?

Chadban, S.; Morris, R.; Hirsch, H.H.; Bunnapradist, S.; Arns, W.; Budde, K., 2008:
Immunosuppression in renal transplantation: some aspects for the modern era

Pierce, S.; Doukas, M.; Waid, T., 1993:
Immunosuppression in renal-transplantation does not increase the incidence of native renal-cancer

Ward, P.A., 2011:
Immunosuppression in sepsis

Heilman, R.L.; Mazur, M.J.; Reddy, K.Sudhakar., 2010:
Immunosuppression in simultaneous pancreas-kidney transplantation: progress to date

Grinyó, J.M.; Cruzado, J.M.; Bestard, O.; Vidal Castiñeira, J.R.; Torras, J., 2012:
Immunosuppression in the era of biological agents

Kawarabayashi, N.; Seki, S.; Hatsuse, K.; Kinoshita, M.; Takigawa, T.; Tsujimoto, H.; Kawabata, T.; Nakashima, H.; Shono, S.; Mochizuki, H., 2010:
Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumor metastasis

Eckman, P.M., 2011:
Immunosuppression in the sensitized heart transplant recipient

Umansky, V., 2012:
Immunosuppression in the tumor microenvironment: where are we standing?

Bayliss, J.; Karasoulos, T.; McLean, C.A., 2013:
Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy

Bayliss, J.; Karasoulos, T.; Bowden, S.; Glogowski, I.; McLean, C.Ann., 2011:
Immunosuppression increases latent infection of brain by JC polyomavirus

Kubera, M.; Filip, Młgorzata.; Budziszewska, Bława.; Basta-Kaim, A.; Wydra, K.; Leskiewicz, M.; Regulska, M.; Jaworska-Feil, L.; Przegalinski, E.; Machowska, A.; Lason, Władysław., 2008:
Immunosuppression induced by a conditioned stimulus associated with cocaine self-administration

Wei, F.; Cao, Y.; Zhang, M.; Huang, R.; Cheng, J.; Xiang, G.; Zhang, J., 2014:
Immunosuppression induced by apoptosis of mixed lymphocyte culture is associated with p53

Son, Y.; Kim, Y., 2011:
Immunosuppression induced by entomopathogens is rescued by addition of apolipophorin III in the diamondback moth, Plutella xylostella

Li, M-Zhong.; Xu, F-De.; Huang, X-Huan.; Chen, X-Chun.; Deng, Q-Wen.; Liu, S-Teng.; Liu, Y.; Xu, L-Mei.; Wang, H-Sheng.; Cui, J-Jun., 2008:
Immunosuppression induced by measles virus in adult patients is not related to CD4+ CD25+ regulatory T cell induction

Mangus, R.S.; Fridell, J.A.; Vianna, R.M.; Kwo, P.Y.; Chen, J.; Tector, A.Joseph., 2012:
Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up

Suzuki, S.; Shibata, M.; Gonda, K.; Kanke, Y.; Ashizawa, M.; Ujiie, D.; Suzushino, S.; Nakano, K.; Fukushima, T.; Sakurai, K.; Tomita, R.; Kumamoto, K.; Takenoshita, S., 2014:
Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer

Ge, W.; Arp, J.; Lian, D.; Liu, W.; Baroja, M.L.; Jiang, J.; Ramcharran, S.; Eldeen, F.Zahr.; Zinser, E.; Steinkasserer, A.; Chou, P.; Brand, S.; Nicolette, C.; Garcia, B.; Wang, H., 2011:
Immunosuppression involving soluble CD83 induces tolerogenic dendritic cells that prevent cardiac allograft rejection

Clancy, M.J.; Marshall, D.; Dilworth, M.; Bottomley, M.; Ashton, N.; Brenchley, P., 2009:
Immunosuppression is essential for successful allogeneic transplantation of the metanephros

Arora, U.; Jagdev, M.; Jindal, N., 2009:
Immunosuppression level in HIV-positive patients with oropharyngeal candidiasis

Le Poole, C.; Denman, C.J.; Arbiser, J.L., 2008:
Immunosuppression may be present within condyloma acuminata

Pellino, G., 2014:
Immunosuppression may exert a hypoxia-mediated carcinogenetic effect in long-standing fistulizing Crohn's disease

Ljung, L.; Smeds, J.; Persson, G.; Jirlén, L.; Toolanen, Göran., 2012:
Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction

Rees, R.C.; Vallely, P.J., 1986:
Immunosuppression mediated by seminal plasma - fact or artefact?

Daher, N.; Lieberman, P., 2010:
Immunosuppression medication as an approach to treat chronic idiopathic urticaria in children

Cantarovich, D.; Vistoli, F.; Soulillou, J-Paul., 2007:
Immunosuppression minimization in kidney transplantation

Sarwal, M.; Pascual, J., 2007:
Immunosuppression minimization in pediatric transplantation

Londoño, M-Carlota.; Rimola, A.; O'Grady, J.; Sanchez-Fueyo, A., 2014:
Immunosuppression minimization vs. complete drug withdrawal in liver transplantation

El-Agroudy, A.E.; El-Dahshan, K.; Mahmoud, K.; Ismail, A.M.; El-Baz, M.; Shokeir, A.A.; Ghoneim, M.A., 2008:
Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy

Fuchs, S.; Feferman, T.; Meidler, R.; Margalit, R.; Sicsic, C.; Brenner, T.; Laub, O.; Souroujon, M.C., 2008:
Immunosuppression of EAMG by IVIG is mediated by a disease-specific anti-immunoglobulin fraction

Del Prete, G.; Chiumiento, L.; Amedei, A.; Piazza, M.; D'Elios, M.M.; Codolo, G.; de Bernard, M.; Masetti, M.; Bruschi, F., 2008:
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori neutrophil-activating protein

Torres-Espín, A.; Redondo-Castro, E.; Hernandez, J.; Navarro, X., 2015:
Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes

Janssen, S.P.M.; Phernambucq, M.; Martinez-Martinez, P.; De Baets, M.H.; Losen, M., 2008:
Immunosuppression of experimental autoimmune myasthenia gravis by mycophenolate mofetil

Shu, J.; Zhang, K-Hua.; Li, H.; Pan, L.; Huang, X-Jie.; Wang, P.; Wang, W-Gang.; Cai, Z., 2015:
Immunosuppression of human amniotic mesenchymal cells on allogeneic peripheral blood lymphocytes

Bae, M-Jung.; Shin, H.Soon.; Shon, D-Hwa., 2013:
Immunosuppression of the trimellitic anhydride-induced th2 response by novel nonanatural products mixture in mice

Eisen, H.J., 2007:
Immunosuppression on the horizon

Scheinberg, P., 2011:
Immunosuppression or immunostimulation for aplastic anemia? A blast from the past

Guan, Z.; Giddens, M.I.; Osmond, D.A.; Cook, A.K.; Hobbs, J.L.; Zhang, S.; Yamamoto, T.; Pollock, J.S.; Pollock, D.M.; Inscho, E.W., 2013:
Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats

Erlandsson, A.; Lin, C-Hsun.Anthony.; Yu, F.; Morshead, C.M., 2011:
Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury

Womer, K.L.; Guerra, G.; Dibadj, K.; Huang, Y.; Kazory, A.; Kaplan, B.; Srinivas, T.R., 2007:
Immunosuppression reduction for BK virus nephropathy: a case for caution

Locke, J.E.; James, N.T.; Mannon, R.B.; Mehta, S.G.; Pappas, P.G.; Baddley, J.W.; Desai, N.M.; Montgomery, R.A.; Segev, D.L., 2014:
Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients

Everly, M.J., 2013:
Immunosuppression regimens to address alloantibodies in transplant recipients

González, A.; Varo, N.; Alegre, E.; Díaz, A.; Melero, I., 2008:
Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach

Sharma, R.; Rajasekar, M.R.; Raghuvanshi, A., 2007:
Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients

Fu, Z-ren.; Shi, X-min.; Teng, F., 2012:
Immunosuppression strategies for liver transplantation

Yango, A.; Johnsingh, A., 2007:
Immunosuppression strategies in kidney transplantation

Irving, C.A.; Webber, S.A., 2010:
Immunosuppression therapy for pediatric heart transplantation

Valabhji, J., 2012:
Immunosuppression therapy posttransplantation can be associated with a different clinical phenotype for diabetic charcot foot neuroarthropathy

Lang, U.E.; Heger, J.; Willbring, M.; Domula, M.; Matschke, K.; Tugtekin, S.M., 2010:
Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement

Yamaguchi, H.; Maruyama, T.; Urade, Y.; Nagata, S., 2014:
Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells

Rusai, K.; Schmaderer, C.; Baumann, M.; Chmielewski, S.; Prókai, A.; Kis, E.; Szabó, A.J.; Leban, J.; Doblhofer, R.; Ammendola, A.; Lutz, J.; Heemann, U., 2012:
Immunosuppression with 4SC-101, a novel inhibitor of dihydroorotate dehydrogenase, in a rat model of renal transplantation

Al-Izki, S.; Pryce, G.; Jackson, S.J.; Giovannoni, G.; Baker, D., 2011:
Immunosuppression with FTY720 is insufficient to prevent secondary progressive neurodegeneration in experimental autoimmune encephalomyelitis

Liu, F.; Luo, X.; Lan, S.; Zhang, X.; Wang, S.; Yang, J.; Levin, L.Scott., 2013:
Immunosuppression with a combination of triptolide and cyclosporin A in rat vascularized groin flap allotransplantation

Koch, M.; Savvatis, K.; Scheeler, M.; Dhayat, S.; Bonaventura, K.; Pohl, T.; Riad, A.; Bulfone-Paus, S.; Schultheiss, H-Peter.; Tschöpe, C., 2010:
Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy

Ferguson, R.; Grinyó, J.; Vincenti, F.; Kaufman, D.B.; Woodle, E.S.; Marder, B.A.; Citterio, F.; Marks, W.H.; Agarwal, M.; Wu, D.; Dong, Y.; Garg, P., 2011:
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients

Bhat, M.; Ghali, P.; Wong, P.; Marcus, V.; Michel, Ré.; Cantarovich, M.; Metrakos, P.; Deschenes, M., 2012:
Immunosuppression with budesonide for liver transplant recipients with severe infections

Mühlen, C.Alberto.von.; Hinterholz, E.Luís.; Garicochea, B.; Weingrill, P.; Barrios, C.; Fernandes, Mário.Sérgio.; Dahmer, Rângela.; Keiserman, M.W.; Staub, H.Luiz., 2004:
Immunosuppression with cyclophosphamide and fudarabine, with support of autologous CD-34+ stem cells, in the treatment of severe scleroderma

Silva, L.A.; Brandão, G.P.; Pinheiro, B.V.; Vitor, R.W.A., 2013:
Immunosuppression with cyclophosphamide favors reinfection with recombinant Toxoplasma gondii strains

Post, M.; Raszeja-Wyszomirska, J.; Jarosz, K.; Lubikowski, J.; Wasilewicz, M.; Mydłowska, M.; Milkiewicz, P.; Wójcicki, M., 2010:
Immunosuppression with low-dose daclizumab in liver transplant recipients with impaired kidney function: a single-center experience

Boesen, E.I.; Williams, D.L.; Pollock, J.S.; Pollock, D.M., 2011:
Immunosuppression with mycophenolate mofetil attenuates the development of hypertension and albuminuria in deoxycorticosterone acetate-salt hypertensive rats

Ghodsizad, A.; Koch, A.; Ungerer, M.N.; Bordel, V.; Zugck, C.; Ehlermann, P.; Doesch, A.; Karck, M.; Ruhparwar, A., 2013:
Immunosuppression with tacrolimus early after orthotopic heart transplantation: a comparison of prograf and advagraf

Nakagawa, K.; Kwak-Kim, J.; Ota, K.; Kuroda, K.; Hisano, M.; Sugiyama, R.; Yamaguchi, K., 2015:
Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios

Mazariegos, G.V., 2011:
Immunosuppression withdrawal after liver transplantation: what are the next steps?

Whitehouse, G.P.; Sanchez-Fueyo, A., 2015:
Immunosuppression withdrawal following liver transplantation

Levitsky, J., 2014:
Immunosuppression withdrawal following liver transplantation: the older, the wiser… but maybe too late

Pons, J.A.; Ramírez, P.; Revilla-Nuin, B.; Pascual, D.; Baroja-Mazo, A.; Robles, R.; Sanchez-Bueno, F.; Martinez, L.; Parrilla, P., 2009:
Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients

Flechner, S.M., 2011:
Immunosuppression without calcineurin inhibition: by ZEUS

Luke, P.P.W.; Nguan, C.Y.; Horovitz, D.; Gregor, L.; Warren, J.; House, A.A., 2008:
Immunosuppression without calcineurin inhibition: optimization of renal function in expanded criteria donor renal transplantation

Abraham, J.M.; Thompson, J.A., 2010:
Immunosuppression, cancer, and the long-term outcomes after liver transplantation: can we do better?

Trofe-Clark, J.; Gabardi, S.; McDevitt-Potter, L.; Alloway, R.R., 2012:
Immunosuppression, generic drugs and the FDA

Okada, S.; Fujimura, T.; Furudate, S.; Kambayashi, Y.; Kikuchi, K.; Aiba, S., 2014:
Immunosuppression-associated eosinophilic pustular folliculitis (IS-EPF) developing after Highly Active Anti-Retroviral Therapy (HAART): the possible mechanisms through CD163+ M2 macrophages

D'Haens, G.; Rutgeerts, P., 2009:
Immunosuppression-associated lymphoma in IBD

Tinguely, M., 2014:
Immunosuppression-associated pathology

Orlando, G., 2012:
Immunosuppression-free transplantation reconsidered from a regenerative medicine perspective

Felton, V.M.; Inge, L.J.; Willis, B.C.; Bremner, R.M.; Smith, M.A., 2011:
Immunosuppression-induced bronchial epithelial-mesenchymal transition: a potential contributor to obliterative bronchiolitis

Vargas, S.O.; Perez-Atayde, A.R.; Padwa, B.L.; Springer, K.M., 2007:
Immunosuppression-related fibroproliferative polyps of the tongue

Gleason, B.C.; Vargas, S.O., 2008:
Immunosuppression-related fibroproliferative polyps: a substantial subset of acquired pediatric mucocutaneous polyps

Beaugerie, L., 2012:
Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?

Eisen, H.J., 2015:
Immunosuppression-state-of-the-art: anything new in the pipeline?

Tabel, H.; Wei, G.; Bull, H.J., 2013:
Immunosuppression: cause for failures of vaccines against African Trypanosomiases

Sprangers, B.; Kuypers, D.R.; Vanrenterghem, Y., 2011:
Immunosuppression: does one regimen fit all?

Benedict, C.A.; Janssen, E.M., 2007:
Immunosuppression: learning from the masters

Porrett, P.M.; Hashmi, S.K.; Shaked, A., 2015:
Immunosuppression: trends and tolerance?

Kawaguchi, N., 2011:
Immunosuppressive / immunomodulating therapies in myasthenia gravis-at present and in the near future

Lin, Y.; Gustafson, M.P.; Bulur, P.A.; Gastineau, D.A.; Witzig, T.E.; Dietz, A.B., 2011:
Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma

Vuk-Pavlović, S.; Bulur, P.A.; Lin, Y.; Qin, R.; Szumlanski, C.L.; Zhao, X.; Dietz, A.B., 2010:
Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

Hu, A-Kang.; Chen, R-Jin.; Zhu, X-Rong.; Gu, J-Hong.; Liu, Z-Ping., 2016:
Immunosuppressive Effect of Hypodermin C on Complement Component 3 In Vitro

Lenhard, M.; Heublein, S.; Kunert-Keil, C.; Vrekoussis, T.; Lomba, I.; Ditsch, N.; Mayr, D.; Friese, K.; Jeschke, U., 2014:
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer

LeBouder, F.; Khoufache, K.; Menier, C.; Mandouri, Y.; Keffous, M.; Lejal, N.; Krawice-Radanne, Iène.; Carosella, E.D.; Rouas-Freiss, N.; Riteau, Béatrice., 2010:
Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection

Xiao, T.; Lu, H-Guang.; Jin, G-Yu.; Wu, J.; Wang, Z-Hua.; Xu, H-Hui.; Gao, X-Hua.; Chen, H-Duo., 2009:
Immunosuppressive Kaposi's sarcoma with bullous pemphigoid associated with hepatitis B virus infection

Ray, A.; Chakraborty, K.; Ray, P., 2013:
Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation

Antunes, M.F.P.; Titz, T.O.; Batista, I.F.C.; Marques-Porto, R.; Oliveira, C.F.; Alves de Araujo, C.A.; Macedo-Soares, M.F., 2016:
Immunosuppressive PAS-1 is an excretory/secretory protein released by larval and adult worms of the ascarid nematode Ascaris suum

Penninga, L.; Møller, C.H.; Gustafsson, F.; Gluud, C.; Steinbrüchel, D.A., 2014:
Immunosuppressive T-cell antibody induction for heart transplant recipients

Drack, A.V.; Mullins, R.F.; Pfeifer, W.L.; Augustine, E.F.; Stasheff, S.F.; Hong, S.D., 2016:
Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease)

Ye, M.; Li, N.; Huang, X.; Wang, D.; Shang, J., 2015:
Immunosuppressive action of dendritic cells sensitized by oligodeoxynucleotides and CA125 on human OVCAR3 ovarian carcinoma xenografts in nude mice

Lu, J.; Guan, S.; Shen, X.; Qian, W.; Huang, G.; Deng, X.; Xie, G., 2011:
Immunosuppressive activity of 8-gingerol on immune responses in mice

Edling, A.E.; Gomes, D.; Weeden, T.; Dzuris, J.; Stefano, J.; Pan, C.; Williams, J.; Kaplan, J.; Perricone, M.A., 2011:
Immunosuppressive activity of a novel peptide analog of α-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis

Jeong, S-H.; Ji, Y-H.; Yoon, E-S., 2015:
Immunosuppressive activity of adipose tissue-derived mesenchymal stem cells in a rat model of hind limb allotransplantation

Guan, S.; Fang, B.; Song, B.; Xiong, Y.; Lu, J., 2015:
Immunosuppressive activity of alpinetin on activation and cytokines secretion of murine T lymphocytes

Hellinger, R.; Koehbach, J.; Fedchuk, H.; Sauer, B.; Huber, R.; Gruber, C.W.; Gründemann, C., 2014:
Immunosuppressive activity of an aqueous Viola tricolor herbal extract

Song, B.; Wang, Z.; Liu, Y.; Xu, S.; Huang, G.; Xiong, Y.; Zhang, S.; Xu, L.; Deng, X.; Guan, S., 2015:
Immunosuppressive activity of daphnetin, one of coumarin derivatives, is mediated through suppression of NF-κB and NFAT signaling pathways in mouse T cells

Mahajan, S.G.; Mehta, A.A., 2010:
Immunosuppressive activity of ethanolic extract of seeds of Moringa oleifera Lam. in experimental immune inflammation

Shuang, G.; Yu, S.; Weixiao, G.; Dacheng, W.; Zhichao, Z.; Jing, L.; Xuming, D., 2011:
Immunosuppressive activity of florfenicol on the immune responses in mice

Xu, Y.; Takahashi, Y.; Yoshimi, A.; Tanaka, M.; Yagasaki, H.; Kojima, S., 2009:
Immunosuppressive activity of mesenchymal stem cells is not decreased in children with aplastic anemia

Guan, S.; Song, Y.; Guo, W.; Chu, X.; Zhang, X.; Wang, D.; Lu, J.; Deng, X., 2012:
Immunosuppressive activity of tilmicosin on the immune responses in mice

Li, J.; Tu, Y.; Tong, L.; Zhang, W.; Zheng, J.; Wei, Q., 2011:
Immunosuppressive activity on the murine immune responses of glycyrol from Glycyrrhiza uralensis via inhibition of calcineurin activity

Raissi, H.; Mollania, F., 2014:
Immunosuppressive agent leflunomide: a SWNTs-immobilized dihydroortate dehydrogenase inhibitory effect and computational study of its adsorption properties on zigzag single walled (6,0) carbon and boron nitride nanotubes as controlled drug delivery devices

Avery, R.K.; Kaplan, B., 2010:
Immunosuppressive agents and CMV risk in the VICTOR study

Sessa, A.; Esposito, A.; Iavicoli, G.D.; Lettieri, E.; Dente, G.; Costa, C.; Bergallo, M.; Rossano, R.; Capuano, M., 2010:
Immunosuppressive agents and bone disease in renal transplant patients with hypercalcemia

Meyer, K.C., 2015:
Immunosuppressive agents and interstitial lung disease: what are the risks?

Sessa, A.; Esposito, A.; Giliberti, A.; Iavicoli, G.; Costa, C.; Bergallo, M.; Lettieri, E.; Rossano, R.; Capuano, M., 2015:
Immunosuppressive agents and metabolic factors of cardiovascular risk in renal transplant recipients

Manitpisitkul, W.; Wilson, N.S.; Haririan, A., 2011:
Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update

Hart, I.K.; Sathasivam, S.; Sharshar, T., 2007:
Immunosuppressive agents for myasthenia gravis

Bressan, A.Lopes.; Silva, R.Souto.da.; Fontenelle, E.; Gripp, A.Carlos., 2010:
Immunosuppressive agents in Dermatology

Nishi, S., 2011:
Immunosuppressive agents in kidney transplantation

Neuhaus, O.; Kieseier, B.C.; Hartung, H-Peter., 2007:
Immunosuppressive agents in multiple sclerosis

Laros-van Gorkom, B.Antonia.Petra.; Falaise, Céline.; Astermark, J., 2015:
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B--a systematic literature review

Földes, Gábor.; Mioulane, M.; Kodagoda, T.; Lendvai, Z.; Iqbal, A.; Ali, N.N.; Schneider, M.D.; Harding, S.E., 2014:
Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells

Subramanian, S.; Trence, D.L., 2007:
Immunosuppressive agents: effects on glucose and lipid metabolism

Wang, Q.; Li, X-Kang., 2011:
Immunosuppressive and anti-inflammatory activities of sinomenine

Ilinskaya, A.N.; Dobrovolskaia, M.A., 2015:
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials

Santangeli, P.; Pieroni, M., 2009:
Immunosuppressive and antiviral treatment of inflammatory cardiomyopathy

Ardizzone, S.; Cassinotti, A.; de Franchis, R., 2013:
Immunosuppressive and biologic therapy for ulcerative colitis

Furudate, S.; Fujimura, T.; Kambayashi, Y.; Haga, T.; Hashimoto, A.; Aiba, S., 2014:
Immunosuppressive and cytotoxic cells in invasive vs. non-invasive Bowen's disease

Smith, M.A.; Hibino, M.; Falcione, B.A.; Eichinger, K.M.; Patel, R.; Empey, K.M., 2014 :
Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients

Hapgood, J.P., 2013:
Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate

Jadhav, G.P.; Chhabra, S.Ram.; Telford, G.; Hooi, D.S.W.; Righetti, K.; Williams, P.; Kellam, B.; Pritchard, D.I.; Fischer, P.M., 2011:
Immunosuppressive but non-LasR-inducing analogues of the Pseudomonas aeruginosa quorum-sensing molecule N-(3-oxododecanoyl)-l-homoserine lactone

Bianchi, G.; Borgonovo, G.; Pistoia, V.; Raffaghello, L., 2011:
Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells

Hula, N.M.; Chumak, A.A.; Mehed', O.F.; Horid'ko, T.M.; Kindruk, N.L.; Berdyshev, A.H., 2008:
Immunosuppressive characteristics of N-stearoylethanolamine a stable compound with cannabimimetic activity

Tramsen, L.; Schmidt, S.; Roeger, F.; Schubert, R.; Salzmann-Manrique, E.; Latgé, J-Paul.; Klingebiel, T.; Lehrnbecher, T., 2014:
Immunosuppressive compounds exhibit particular effects on functional properties of human anti-Aspergillus Th1 cells

Hou, W-Rui.; Su, Z-Qiang.; Pi, H-Fang.; Yao, G-Min.; Zhang, P.; Luo, X.; Xie, S-Nan.; Xiang, M., 2010:
Immunosuppressive constituents from Urtica dentata Hand

Han, W.; Ming, M.; He, T-Chuan.; He, Y-Ying., 2010:
Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis

Syrjänen, S.; Naud, P.; Sarian, L.; Derchain, S.; Roteli-Martins, C.; Longatto-Filho, A.; Tatti, S.; Branca, M.; Erzen, M.; Hammes, L.S.; Costa, S.; Syrjänen, K., 2010:
Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort

Xiao, H.; Cao, W.; Lai, X.; Luo, Y.; Shi, J.; Tan, Y.; He, J.; Xie, W.; Meng, X.; Zheng, W.; Zheng, G.; Han, X.; Jin, L.; Zhang, L.; Wang, Y.; Yu, X.; Cai, Z.; Lin, M.; Ye, X.; Huang, H., 2011:
Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese population

Zhu, L.; Lu, J-Guang.; Li, T.; Zhu, G-Yuan.; Han, Q-Bin.; Hsiao, W-Luan.; Liu, L.; Jiang, Z-Hong., 2012:
Immunosuppressive decalin derivatives from red yeast rice

McCarter, M.D.; Baumgartner, J.; Escobar, G.A.; Richter, D.; Lewis, K.; Robinson, W.; Wilson, C.; Palmer, B.E.; Gonzalez, R., 2007:
Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients

Sunesen, Kåre.G.; Nørgaard, M.; Thorlacius-Ussing, O.; Laurberg, Søren., 2010:
Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005

Marinkovic, G.; Hibender, S.; Hoogenboezem, M.; van Broekhoven, A.; Girigorie, A.F.; Bleeker, N.; Hamers, A.A.J.; Stap, J.; van Buul, J.D.; de Vries, C.J.M.; de Waard, V., 2013:
Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-kinase in endothelial cells

Nakazawa, N.; Niijima, S.; Tanaka, Y.; Ito, T., 2013:
Immunosuppressive drug rapamycin restores sporulation competence in industrial yeasts

Hartono, C.; Muthukumar, T.; Suthanthiran, M., 2014:
Immunosuppressive drug therapy

Stucker, F.; Ackermann, D., 2012:
Immunosuppressive drugs - how they work, their side effects and interactions

van Sandwijk, M.S.; Bemelman, F.J.; Ten Berge, I.J.M., 2014:
Immunosuppressive drugs after solid organ transplantation

De Serres, S.A.; Sayegh, M.H.; Najafian, N., 2010:
Immunosuppressive drugs and Tregs: a critical evaluation!

Coscia, L.A.; Constantinescu, S.; Davison, J.M.; Moritz, M.J.; Armenti, V.T., 2015:
Immunosuppressive drugs and fetal outcome

Moretto, J.; Bessard, G.; Stanke-Labesque, Fçoise., 2007:
Immunosuppressive drugs and highly active antiretroviral therapy: pharmacokinetic interactions

Gjersvik, P.; Helsing, P.; Holdaas, H.; Bergan, S., 2013:
Immunosuppressive drugs and the development of skin cancer after organ transplantation

Gasser, O.; Zenhaeusern, G.; Hönger, G.; Brander, C.; Hess, C., 2011:
Immunosuppressive drugs asymmetrically impact circulating T cell counts and function

Pezzilli, R., 2014:
Immunosuppressive drugs for the treatment of autoimmune pancreatitis

Salinas-Carmona, M.C.; Perez, L.Isabel.; Galan, K.; Vazquez, A.Velia., 2009:
Immunosuppressive drugs have different effect on B lymphocyte subsets and IgM antibody production in immunized BALB/c mice

Marcén, R., 2009:
Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection

Stucker, F.; Marti, H-Peter.; Hunger, R.E., 2012:
Immunosuppressive drugs in organ transplant recipients--rationale for critical selection

Wang, J.; Wang, B.; Huang, S.; Song, Z.; Wu, J.; Zhang, E.; Zhu, Z.; Zhu, B.; Yin, Y.; Lin, Y.; Xu, Y.; Zheng, X.; Lu, M.; Yang, D., 2014:
Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model

Wu, T.; Zhang, L.; Xu, K.; Sun, C.; Lei, T.; Peng, J.; Liu, G.; Wang, R.; Zhao, Y., 2013:
Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo

Gil, S., 2013:
Immunosuppressive drugs, corticosteroids and pregnancy

Rahamimoff, H.; Elbaz, B.; Valitsky, M.; Khatib, M.; Eskin-Schwartz, M.; Elmaz, D., 2013:
Immunosuppressive drugs, immunophilins, and functional expression of NCX isoforms

Tang, J.; Tian, D.; Liu, G., 2011:
Immunosuppressive effect of Cordyceps CS-4 on human monocyte-derived dendritic cells in vitro

Hida, T.; Shikata, K.; Tokuhara, N.; Ishibashi, A.; Nagai, M.; Yamauchi, T.; Kobayashi, S., 2008:
Immunosuppressive effect of ER-38925, a retinoic acid receptor subtype α-selective agonist, in mouse models of human graft-vs-host disease

Chen, Y-Bing.; Li, S-Dan.; He, Y-Ping.; Shi, X-Jie.; Chen, Y.; Gong, J-Ping., 2009:
Immunosuppressive effect of IDO on T cells in patients with chronic hepatitis B*

Zhou, W-Qi.; Zhang, H-Jing.; Jin, J.; Li, Y.; Li, C.; Chen, X-Guang., 2013:
Immunosuppressive effect of S1P1 receptor agonist FTY720

Maeda, A.; Okazaki, T.; Inoue, M.; Kitazono, T.; Yamasaki, M.; Lemonnier, Fçois.A.; Ozaki, S., 2010:
Immunosuppressive effect of angiotensin receptor blocker on stimulation of mice CTLs by angiotensin II

Sagynbaeva, V.É.; Lazebnik, L.B., 2014:
Immunosuppressive effect of bone marrow MSC transplantation in patients with ulcerative colitis with six kinds of one family autoantibodies with cross-relationship between each other

Han, Z.; Tian, Z.; Lv, G.; Zhang, L.; Jiang, G.; Sun, K.; Wang, C.; Bu, X.; Li, R.; Shi, Y.; Wu, M.; Wei, L., 2012:
Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells

Ma, P-Fei.; Jiang, J.; Gao, C.; Cheng, P-Pan.; Li, J-Li.; Huang, X.; Lin, Y-Ying.; Li, Q.; Peng, Y-Zheng.; Cai, M-Chun.; Shao, W.; Zhu, Q.; Han, S.; Qin, Q.; Xia, J-Jie.; Qi, Z-Quan., 2014:
Immunosuppressive effect of compound K on islet transplantation in an STZ-induced diabetic mouse model

Zhang, Y-xiang.; Sun, H-xiang., 2010:
Immunosuppressive effect of ethanol extract of Artemisia annua on specific antibody and cellular responses of mice against ovalbumin

He, Y-ping.; Chen, Y-bing.; Gong, J-ping., 2010:
Immunosuppressive effect of indoleamine 2, 3-dioxygenase on T cells in patients with chronic hepatitis B

Pejkovski, C.; Davelaar, F.G.; Kouwenhoven, B., 1979:
Immunosuppressive effect of infectious bursal disease virus on vaccination against infectious bronchitis

Sugiura, S.; Fujimiya, M.; Ebise, H.; Miyahira, Y.; Kato, I.; Sugiura, Y.; Kimura, T.; Uehara, M.; Sato, H.; Sugiura, H., 2012:
Immunosuppressive effect of prolactin-induced protein

Sugiura, S.; Fujimiya, M.; Ebise, H.; Miyahira, Y.; Kato, I.; Sugiura, Y.; Kimura, T.; Uehara, M.; Sato, H.; Sugiura, H., 2011:
Immunosuppressive effect of prolactin-induced protein: a new insight into its local and systemic role in chronic allergic contact dermatitis

Huang, R-Yeong.; Yu, Y-Ling.; Cheng, W-Chien.; OuYang, C-Nan.; Fu, E.; Chu, C-Liang., 2010:
Immunosuppressive effect of quercetin on dendritic cell activation and function

Shigematsu, Y.; Hanagiri, T.; Shiota, H.; Kuroda, K.; Baba, T.; Ichiki, Y.; Yasuda, M.; Uramoto, H.; Takenoyama, M.; Yasumoto, K.; Tanaka, F., 2012:
Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes

Teng, L.; Chen, Y.; Ding, D.; Dai, H.; Liu, G.; Li, C., 2015:
Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells

Gharagozloo, M.; Jafari, S.; Esmaeil, N.; Javid, E.N.; Bagherpour, B.; Rezaei, A., 2013:
Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production

Radu, C.A.; Bosch, N.; Bauer, T.M.; Kleist, C.; Jiga, L.; Terness, P.; Opelz, G.; Gebhard, M.M.; Germann, G.; Baumeister, S., 2007:
Immunosuppressive effect of tryptophan metabolites in composite tissue allotransplantation

Matsumoto, Y.; Fujita, T.; Hirai, I.; Sahara, H.; Torigoe, T.; Ezoe, K.; Saito, T.; Cruikshank, W.W.; Yotsuyanagi, T.; Sato, N., 2008:
Immunosuppressive effect on T cell activation by interleukin-16- and interleukin-10-cDNA-double-transfected human squamous cell line

Kelly, M.E.; Juern, A.M.; Grossman, W.J.; Schauer, D.W.; Drolet, B.A., 2010:
Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas

Shibasaki, S.; Yamashita, K.; Goto, R.; Wakayama, K.; Tsunetoshi, Y.; Zaitsu, M.; Igarashi, R.; Haga, S.; Ozaki, M.; Umezawa, K.; Todo, S., 2013:
Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway

Ahmad, S.Fayaz.; Khan, B.; Bani, S.; Kaul, A.; Sultan, P.; Ali, S.Abid.; Satti, N.K.; Bakheet, S.A.; Attia, S.M.; Zoheir, K.M.A.; Abd-Allah, A.R.A., 2014:
Immunosuppressive effects of Euphorbia hirta in experimental animals

Caniceiro, B.D.; Latorre, A.O.; Fukumasu, H.; Sanches, D.S.; Haraguchi, M.; Górniak, S.L., 2015:
Immunosuppressive effects of Pteridium aquilinum enhance susceptibility to urethane-induced lung carcinogenesis

Xiang, M.; Hou, W-Rui.; Xie, S-Nan.; Zhang, W-Dong.; Wang, X., 2010:
Immunosuppressive effects of an ethyl acetate extract from Urtica dentata Hand on skin allograft rejection

Xu, W.; Lin, Z.; Yang, C.; Zhang, Y.; Wang, G.; Xu, X.; Lv, Q.; Ren, Y.; Dong, Y., 2009:
Immunosuppressive effects of demethylzeylasteral in a rat kidney transplantation model

Liu, Y-X.; Shen, N-Y.; Liu, C.; Lv, Y., 2009:
Immunosuppressive effects of emodin: an in vivo and in vitro study

Cravedi, P.; Manrique, J.; Hanlon, K.E.; Reid-Adam, J.; Brody, J.; Prathuangsuk, P.; Mehrotra, A.; Heeger, P.S., 2014:
Immunosuppressive effects of erythropoietin on human alloreactive T cells

Li, F.; Lyu, J.; Duan, Y.; Sun, Y.; Li, D.; Wang, Y.; Hu, X.; Xiao, D., 2015:
Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors

Kim, G-Dong.; Lee, S.Eun.; Park, Y.Seek.; Shin, D-Hoon.; Park, G.Gun.; Park, C-Seog., 2015:
Immunosuppressive effects of fisetin against dinitrofluorobenzene-induced atopic dermatitis-like symptoms in NC/Nga mice

Wu, M-Yao.; Hung, S-Kai.; Fu, S-Ling., 2012:
Immunosuppressive effects of fisetin in ovalbumin-induced asthma through inhibition of NF-κB activity

Tanaka, Y., 2008:
Immunosuppressive effects of glucocoriticoid

Panossian, A.G.; Gabrielian, E.; Manvelian, V.; Jurcic, K.; Wagner, H., 1996:
Immunosuppressive effects of hypericin on stimulated human leukocytes: inhibition of the arachidonic acid release, leukotriene B(4) and Interleukin-Iα production, and activation of nitric oxide formation

Mao, F.; Xu, W-Rong.; Qian, H.; Zhu, W.; Yan, Y-Min.; Shao, Q-Xiang.; Xu, H-Xi., 2010:
Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis

Hallett, W.H.D.; Jing, W.; Drobyski, W.R.; Johnson, B.D., 2012:
Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade

Pan, R-Le.; Chen, D-Hua.; Si, J-Yong.; Zhao, X-Hong.; Li, Z.; Cao, L., 2009:
Immunosuppressive effects of new cyclolanostane triterpene diglycosides from the aerial part of Cimicifuga foetida

Hayami, J.; Okamoto, H.; Sugihara, A.; Horio, T., 2007:
Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid

Ye, Z.; Wang, Y.; Xie, H-Yang.; Zheng, S-Sen., 2009:
Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells

Lee, W-Gil.; Kim, W-Seok.; Park, S-Gyoo.; Kim, H.; Hong, J.; Ko, H.; Kim, Y-Chul., 2012:
Immunosuppressive effects of subglutinol derivatives

Yoshino, T.; Nakase, H.; Honzawa, Y.; Matsumura, K.; Yamamoto, S.; Takeda, Y.; Ueno, S.; Uza, N.; Masuda, S.; Inui, K.; Chiba, T., 2011:
Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis

Udoji, F.; Martin, T.; Etherton, R.; Whalen, M.M., 2011:
Immunosuppressive effects of triclosan, nonylphenol, and DDT on human natural killer cells in vitro

Ng, S.C.; Plamondon, S.; Kamm, M.A.; Hart, A.L.; Al-Hassi, H.Omar.; Guenther, T.; Stagg, A.J.; Knight, S.C., 2010:
Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis

Yang, C.; Robbins, P.D., 2012:
Immunosuppressive exosomes: a new approach for treating arthritis

Sioud, M.; Mobergslien, A.; Sæbøe-Larssen, S., 2015:
Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses

Hong, Z-F.; Huang, X-J.; Yin, Z-Y.; Zhao, W-X.; Wang, X-M., 2009:
Immunosuppressive function of bone marrow mesenchymal stem cells on acute rejection of liver allografts in rats

Ma, L.; Zhou, Z.; Zhang, D.; Yang, S.; Wang, J.; Xue, F.; Yang, Y.; Yang, R., 2012:
Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients

Liao, J-Jun.; Huang, M-Chuan.; Fast, K.; Gundling, K.; Yadav, M.; Van Brocklyn, J.R.; Wabl, M.R.; Goetzl, E.J., 2009:
Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor

Sarikonda, G.; von Herrath, M.G., 2011:
Immunosuppressive mechanisms during viral infectious diseases

Tanaka, Y., 2009:
Immunosuppressive mechanisms in diabetes mellitus

Han, K.Hyun.; Ro, H.; Hong, J.Ho.; Lee, E.Mi.; Cho, B.; Yeom, H.Jung.; Kim, M-Gyu.; Oh, K-Hwan.; Ahn, C.; Yang, J., 2011:
Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response

Lalić, J.; Veličković-Radovanović, R.; Mitić, B.; Paunović, G.; Cvetković, T., 2015:
Immunosuppressive medication adherence in kidney transplant patients

Elliott, A.B.; Chakravarty, E.F., 2010:
Immunosuppressive medications during pregnancy and lactation in women with autoimmune diseases

Roland, Mélanie.; Gatault, P.; Doute, C.; Büchler, M.; Al-Najjar, A.; Barbet, C.; Chatelet, Vérie.; Marlière, J-Frédéric.; Nivet, H.; Lebranchu, Y.; Halimi, J-Michel., 2008:
Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation

Pistoia, V.; Morandi, F.; Bianchi, G.; Pezzolo, A.; Prigione, I.; Raffaghello, L., 2013:
Immunosuppressive microenvironment in neuroblastoma

Kurmaeva, E.; Bhattacharya, D.; Goodman, W.; Omenetti, S.; Merendino, A.; Berney, S.; Pizarro, T.; Ostanin, D.V., 2015:
Immunosuppressive monocytes: possible homeostatic mechanism to restrain chronic intestinal inflammation

Ding, Z-Chun.; Lu, X.; Yu, M.; Lemos, H.; Huang, L.; Chandler, P.; Liu, K.; Walters, M.; Krasinski, A.; Mack, M.; Blazar, B.R.; Mellor, A.L.; Munn, D.H.; Zhou, G., 2014:
Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis

Ko, H-Jeong.; Lee, J-Mi.; Kim, Y-Jeong.; Kim, Y-Sun.; Lee, K-A.; Kang, C-Yuil., 2009:
Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine

Chavis, P.S.; Stickler, D.E.; Walker, A., 2007:
Immunosuppressive or surgical treatment for ocular Myasthenia Gravis

Ribichini, F.; Tomai, F.; Ferrero, V.; Versaci, F.; Boccuzzi, G.; Proietti, I.; Prati, F.; Crea, F.; Vassanelli, C., 2005:
Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study

Thell, K.; Hellinger, R.; Schabbauer, G.; Gruber, C.W., 2015:
Immunosuppressive peptides and their therapeutic applications

Zhang, Y.L.; Zhang, J.; Jiang, N.; Lu, Y.H.; Wang, L.; Xu, S.H.; Wang, W.; Zhang, G.F.; Xu, Q.; Ge, H.M.; Ma, J.; Song, Y.C.; Tan, R.X., 2011:
Immunosuppressive polyketides from mantis-associated Daldinia eschscholzii

Katoch, M.; Khajuria, A.; Sharma, P.R.; Saxena, A.Kumar., 2015:
Immunosuppressive potential of Botryosphaeria dothidea, an endophyte isolated from Kigelia africana

Kitsukawa, M.; Tsuchiyama, H.; Maeda, A.; Oshida, K.; Miyamoto, Y., 2015:
Immunosuppressive potential of bardoxolone methyl using a modified murine local lymph node assay (LLNA)

Bhagwat, D.P.; Kharya, M.D.; Bani, S.; Kaul, A.; Kour, K.; Chauhan, P.Singh.; Suri, K.A.; Satti, N.K., 2010:
Immunosuppressive properties of Pluchea lanceolata leaves

Richards, E.H.; Dani, M.P.; Bradish, H., 2013:
Immunosuppressive properties of a protein (rVPr1) from the venom of the endoparasitic wasp, Pimpla hypochondriaca: Mechanism of action and potential use for improving biological control strategies

Påhlman, C.; Qi, Z.; Murray, C.M.; Ferguson, D.; Bundick, R.V.; Donald, D.K.; Ekberg, H., 2013:
Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1

Zhi-Gang, Z.; Wei-Ming, L.; Zhi-Chao, C.; Yong, Y.; Ping, Z., 2008:
Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases

De Miguel, M.P.; Fuentes-Julián, S.; Blázquez-Martínez, A.; Pascual, C.Y.; Aller, M.A.; Arias, J.; Arnalich-Montiel, F., 2012:
Immunosuppressive properties of mesenchymal stem cells: advances and applications

Bray, L.J.; Heazlewood, C.F.; Munster, D.J.; Hutmacher, D.W.; Atkinson, K.; Harkin, D.G., 2014:
Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas

Imai, A.; Sugita, S.; Kawazoe, Y.; Horie, S.; Yamada, Y.; Keino, H.; Maruyama, K.; Mochizuki, M., 2013:
Immunosuppressive properties of regulatory T cells generated by incubation of peripheral blood mononuclear cells with supernatants of human RPE cells

Streilein, J.W.; Bradley, D.; Sano, Y., 1996:
Immunosuppressive properties of tissues of the ocular anterior segment

Park, C.Yong.; Kohanim, S.; Zhu, L.; Gehlbach, P.L.; Chuck, R.S., 2009:
Immunosuppressive property of dried human amniotic membrane

Saumyaa; Arjunaraja, S.; Pujanauski, L.; Colino, J.; Torres, R.M.; Snapper, C.M., 2014:
Immunosuppressive property within the Streptococcus pneumoniae cell wall that inhibits generation of T follicular helper, germinal center, and plasma cell response to a coimmunized heterologous protein

Mortazavi, M.; Akbarzadeh, A.; Farhangi, A.; Mehrabi, M.; Hosseinian, Z.; Mokhtari, M.J.; Saffari, Z., 2011:
Immunosuppressive proteins isolated from spiral and coccoid cytoplasmic solutions of Helicobacter pylori

Matia, I.; Fellmer, P.; Splith, K.; Varga, M.; Adamec, M.; Kämmerer, I.; Feldbrügge, L.; Krenzien, F.; Hau, H-Michael.; Atanasov, G.; Schmelzle, M.; Jonas, S., 2014:
Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats

Ravindra, K.V.; Ildstad, S.T., 2012:
Immunosuppressive protocols and immunological challenges related to hand transplantation

Gruber, T.D.; Krishnamurthy, C.; Grimm, J.B.; Tadross, M.R.; Wysocki, L.M.; Gartner, Z.J.; Lavis, L.D., 2018:
Cell-Specific Chemical Delivery Using a Selective Nitroreductase-Nitroaryl Pair

Gelens, Mëlle.A.C.J.; Steegh, F.M.E.G.; van Hooff, J.P.; van Suylen, R.Jan.; Nieman, F.H.M.; van Heurn, L.W.E.; Peutz-Kootstra, C.J.; Christiaans, M.H.L., 2012:
Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant

Przybylowski, P.; Malyszko, J.; Malyszko, J., 2011:
Immunosuppressive regimen and prevalence of chronic kidney disease in orthotopic heart transplant recipients

Loeffelbein, D.J.; Szilinski, K.; Hölzle, F., 2010:
Immunosuppressive regimen influences incidence of skin cancer in renal and pancreatic transplant recipients

Rutkowski, Bław.; Bzoma, B.; Dębska-Ślizień, A.; Chamienia, A., 2012:
Immunosuppressive regimens containing generic mycophenolate mofetil (Myfenax) in de novo renal transplant recipients--preliminary results of 6-month observation

Ge, H.Ming.; Yang, W.Hao.; Shen, Y.; Jiang, N.; Guo, Z.Kai.; Luo, Q.; Xu, Q.; Ma, J.; Tan, R.Xiang., 2010:
Immunosuppressive resveratrol aneuploids from Hopea chinensis

McKee, S.J.; Mattarollo, S.R.; Leggatt, G.R., 2014:
Immunosuppressive roles of natural killer T (NKT) cells in the skin

Phillips, R.; Sarfo, F.S.; Guenin-Macé, L.; Decalf, Jérémie.; Wansbrough-Jones, M.; Albert, M.L.; Demangel, C., 2009:
Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease

Geppert, T.; Bauer, S.; Hiss, J.A.; Conrad, E.; Reutlinger, M.; Schneider, P.; Weisel, M.; Pfeiffer, B.; Altmann, K-Heinz.; Waibler, Z.; Schneider, G., 2012:
Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions

Hazzan, M.; Glowacki, F.; Lionet, A.; Provot, F.; Noël, C., 2008:
Immunosuppressive strategies and chronic graft dysfunction in kidney transplantation

Fernández Rodríguez, A.M.; Marcén Letosa, R., 2008:
Immunosuppressive strategies in elderly recipients

Tang, I.Y.; Meier-Kriesche, H-Ulf.; Kaplan, B., 2007:
Immunosuppressive strategies to improve outcomes of kidney transplantation

Perkins, J.D., 2009:
Immunosuppressive strategies to prevent hepatitis C recurrence

Di Benedetto, F.; Di Sandro, S.; De Ruvo, N.; Montalti, R.; Guerrini, G.P.; Ballarin, R.; Spaggiari, M.; Mimmo, A.; D'Amico, G.; Cautero, N.; Iemmolo, R.M.; Gerunda, G.E., 2014:
Immunosuppressive switch to sirolimus in renal dysfunction after liver transplantation

Zambernardi, A.; Chiodetti, A.; Meier, D.; Cabanne, A.; Nachman, F.; Solar, Héctor.; Rumbo, C.; Gondolesi, G.E.; Rumbo, M., 2015:
Immunosuppressive therapies after intestinal transplant modulate the expression of Th1 signature genes during acute cellular rejection. Implications in the search for rejection biomarkers

Zenlea, T.; Peppercorn, M.A., 2015:
Immunosuppressive therapies for inflammatory bowel disease

Mitarai, T., 2011:
Immunosuppressive therapies for refractory nephrotic syndrome

Tian, S.Yu.; Feldman, B.M.; Beyene, J.; Brown, P.E.; Uleryk, E.M.; Silverman, E.D., 2016:
Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis

Sanders, D.B.; Evoli, A., 2010:
Immunosuppressive therapies in myasthenia gravis

Risitano, A.M., 2012:
Immunosuppressive therapies in the management of acquired immune-mediated marrow failures

Risitano, A.M., 2011:
Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going

Metalidis, C.; Kuypers, D., 2011:
Immunosuppressive therapy after kidney transplantation: current and new strategies

Hofbauer, G., 2010:
Immunosuppressive therapy after transplantation. Dermatologic relevance and pathomechanisms

Cuarterolo, M.L.; Ciocca, M.E.; López, S.I.; de Dávila, Mía.T.G.; Alvarez, F., 2011:
Immunosuppressive therapy allows recovery from liver failure in children with autoimmune hepatitis

Fortun, J.; Martin-Davila, P.; Pascual, J.; Cervera, C.; Moreno, A.; Gavalda, J.; Aguado, J.M.; Pereira, P.; Gurguí, M.; Carratala, J.; Fogueda, M.; Montejo, M.; Blasco, F.; Bou, G.; Torre-Cisneros, J., 2011:
Immunosuppressive therapy and infection after kidney transplantation

Perkins, J.D., 2008:
Immunosuppressive therapy and inflammatory bowel disease after transplantation

Kuman, M., 2011:
Immunosuppressive therapy and its problems

Moriyama, T., 2009:
Immunosuppressive therapy and life-style related diseases

Gutierrez-Dalmau, A.; Campistol, J.M., 2007:
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review

Domhan, S.; Zeier, M.; Abdollahi, A., 2008:
Immunosuppressive therapy and post-transplant malignancy

Yamamoto, T., 2013:
Immunosuppressive therapy and postoperative complications in Crohn's disease

Starzl, T.E., 2008:
Immunosuppressive therapy and tolerance of organ allografts

Yoshikawa, K.; Yano, S., 2010:
Immunosuppressive therapy and tuberculosis

Bafford, A.C.; Powers, S.; Ha, C.; Kruse, D.; Gorfine, S.R.; Chessin, D.B.; Bauer, J.J., 2013:
Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease

Kaminitz, A.; Mizrahi, K.; Yaniv, I.; Stein, J.; Askenasy, N., 2011:
Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells

Buniel, M.C.; Geelan-Hansen, K.; Weber, P.C.; Tuohy, V.K., 2011:
Immunosuppressive therapy for autoimmune inner ear disease

Meyer, K.C.; Bierach, J., 2013:
Immunosuppressive therapy for autoimmune lung diseases

Al-Ghazlat, S., 2013:
Immunosuppressive therapy for canine immune-mediated hemolytic anemia

Wojnicz, R., 2007:
Immunosuppressive therapy for heart failure

Dobbelstein, C.; Ganser, A., 2012:
Immunosuppressive therapy for myelodysplastic syndromes

Barrett, A.John.; Sloand, E.M., 2010:
Immunosuppressive therapy for myelodysplastic syndromes: refining the indications

Jap, A.; Chee, S-Phaik., 2008:
Immunosuppressive therapy for ocular diseases

Passweg, J.R.; Giagounidis, A.A.N.; Simcock, M.; Aul, C.; Dobbelstein, C.; Stadler, M.; Ossenkoppele, G.; Hofmann, W-Karsten.; Schilling, K.; Tichelli, Aé.; Ganser, A., 2011:
Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99

Zeniya, M.; Wada, T., 2014:
Immunosuppressive therapy for primary biliary cirrhosis: Do we need in future?

Nair, V.; Sharma, A.; Das, S.; Sondhi, V.; Sharma, S., 2014:
Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India

Prasad, R.; Singh, U.Kant.; Mittal, R.; Mishra, O.P., 2011:
Immunosuppressive therapy in children

Sterry, W.; Bagot, M.; Ferrandiz, C.; Kragballe, K.; Papp, K.; Stingl, G., 2009:
Immunosuppressive therapy in dermatology and PML

Smogorzewski, Mław.J.; Lao, Mław.; Gradowska, L.; Rowińska, D.; Rancewicz, Z.; Orłowski, T., 2009:
Immunosuppressive therapy in glomerular diseases: major accomplishment of Tadeusz Orłowski and his school

Abhyankar, A.; Tapper, E.; Bonder, A., 2014:
Immunosuppressive therapy in immune-mediated liver disease in the non-transplanted patient

Balkrishnan, C.; Sharma, V.; Vyas, A., 2011:
Immunosuppressive therapy in inflammatory ocular surface disease post Steven Johnson syndrome

Korom, S.; Boehler, A.; Weder, W., 2009:
Immunosuppressive therapy in lung transplantation: state of the art

Jais, X.; Launay, D.; Yaici, A.; Le Pavec, Jérôme.; Tchérakian, C.; Sitbon, O.; Simonneau, Gérald.; Humbert, M., 2008:
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases

Hanauer, S.B., 2008:
Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease

Antiga, E.; Fabbri, P.; Caproni, M., 2010:
Immunosuppressive therapy may affect the number of circulating regulatory cells in systemic sclerosis: Pay attention to the patient selection criteria

Swijnenburg, R-Jan.; Schrepfer, S.; Govaert, J.A.; Cao, F.; Ransohoff, K.; Sheikh, A.Y.; Haddad, M.; Connolly, A.J.; Davis, M.M.; Robbins, R.C.; Wu, J.C., 2008:
Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts

Song, Y.; Du, X.; Hao, F.; Gu, X.; Zhang, Z.; Zhang, S.; Li, C.; Li, H.; Ma, J., 2010:
Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up

Quereda, C.; Ballarín, J.; Galeano, C.; García López, F.; Praga, M., 2007:
Immunosuppressive therapy of primary focal sclerosing glomerulonephritis in the adult: a systematic review

Litman, N.N., 1972:
Immunosuppressive therapy of renal disease

Sato, K., 2011:
Immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection

Yoshida, M., 2010:
Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome

Liu, X.; Zou, Y.; Wang, S.; Zhang, L.; Yang, W.; Zhang, J.; Liu, F.; Liu, T.; Chen, X.; Ruan, M.; Zhou, J.; Cai, X.; Qi, B.; Chang, L.; An, W.; Guo, Y.; Chen, Y.; Zhu, X., 2014:
Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia

Nakasone, H.; Iijima, K.; Asano, H.; Nakamura, F.; Kida, M.; Izutsu, K.; Urabe, A.; Usuki, K., 2008:
Immunosuppressive therapy with antithymocyte globulin and cyclosporine for paroxysmal nocturnal hemoglobinuria

Yagasaki, H.; Shichino, H.; Ohara, A.; Kobayashi, R.; Yabe, H.; Ohga, S.; Hamamoto, K.; Ohtsuka, Y.; Shimada, H.; Inoue, M.; Muramatsu, H.; Takahashi, Y.; Kojima, S., 2014:
Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children

Fasoli, G., 2007:
Immunosuppressive therapy without calcineurin inhibitors for renal transplants? Perhaps we should be cautions...

Deyell, R.J.; Shereck, E.B.; Milner, R.A.; Schultz, K.R., 2011:
Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia

Niaudet, P., 2012:
Immunosuppressive treatment

Zhang, X-Dong.; Guo, S-Zhong.; Han, Y.; Lu, B-Lun.; Wen, A-Dong.; Yang, L.; Zhang, H.; Wang, D-Tai.; Liu, Y-Jing.; Fan, X., 2007:
Immunosuppressive treatment about the patient operated facial allotransplantation in perioperative period

Biancone, L.; Lavacca, A.; Beltramo, S.; Ariaudo, C.; Gallo, E.; Segoloni, G.Paolo., 2013:
Immunosuppressive treatment after kidney transplant: the frontier of chronic antibody-mediated rejection

Ingvar, A.; Smedby, K.Ekström.; Lindelöf, B.; Fernberg, P.; Bellocco, R.; Tufveson, G.; Höglund, P.; Adami, J., 2010:
Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma

Zhang, X.Hui.; Feng, R.; Xu, L.Ping.; Jiang, Q.; Jiang, H.; Fu, H.Xia.; Liu, H.; Niu, T.; Wang, X.; Hu, J.Da.; Jiang, M.; Wang, Z.; Wang, J.Wen.; Ma, H.; Xie, Y.Di.; Zhu, X.Lu.; Wang, H.; Wei, L.; Huang, X-Jun., 2016:
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study

Martín-Rubí, J.C.; Marruecos-Sant, L.; Palomar-Martínez, M.; Martínez-Escobar, S., 2007:
Immunosuppressive treatment due to paraquat poisoning

Tiede, A.; Huth-Kühne, A.; Oldenburg, J.; Grossmann, R.; Geisen, U.; Krause, M.; Brand, B.; Alberio, L.; Klamroth, R.; Spannagl, M.; Knöbl, P., 2009:
Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland

Passweg, J.R.; Tichelli, Aé., 2009:
Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?

Braun, N.; Schmutzler, F.; Lange, C.; Perna, A.; Remuzzi, G.; Risler, T.; Willis, N.S., 2008:
Immunosuppressive treatment for focal segmental glomerulosclerosis in adults

Chen, Y.; Schieppati, A.; Chen, X.; Cai, G.; Zamora, J.; Giuliano, G.A.; Braun, N.; Perna, A., 2014:
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome

Pirisi, M.; Faedda, R.; Satta, A.; Bartoli, E., 2008:
Immunosuppressive treatment for idiopathic nephrotic syndrome with corticosteroids and cyclophosphamide: factors associated with a favourable outcome

Zivčić-Ćosić, S.; Trobonjača, Z.; Rački, S., 2016:
Immunosuppressive treatment for kidney transplantation

Lu, C.; Qin, F.; Yan, Y.; Liu, T.; Li, J.; Chen, H., 2017:
Immunosuppressive treatment for myocarditis: a meta-analysis of randomized controlled trials

Xie, G.; Xu, J.; Ye, C.; Chen, D.; Xu, C.; Yang, L.; Ma, Y.; Hu, X.; Li, L.; Sun, L.; Zhao, X.; Mao, Z.; Mei, C., 2013:
Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults

Yıldırmak, Yıldız.; Erdem, E.; Telhan, L.; Kepekçi, L., 2012:
Immunosuppressive treatment in children with acquired aplastic anemia

Tanna, S.; Ustun, C., 2010:
Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?

Pérez Fontán, M.; Rodríguez-Carmona, A., 2008:
Immunosuppressive treatment in patients starting peritoneal dialysis after functional arrest of kidney transplant. What to do?

Xu, S.; Xu, G.; Zeng, L., 2013:
Immunosuppressive treatment in primary focal segmental glomerulosclerosis

Muslimović, A.; Rasić, S.; Rebić, D.; Uncanin, S., 2010:
Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome

Filippone, E.J., 2013:
Immunosuppressive treatment of idiopathic membranous nephropathy: the dilemma continues

Martín-Gómez, Aón., 2013:
Immunosuppressive treatment of lupus nephritis in severe renal impairment. About the ALMS study

Sibilia, J.; Carles, P., 2007:
Immunosuppressive treatment: administration, adverse effect, prophylactic measures

Piccin, A.; Cortelazzo, S.; Rovigatti, U.; Bourke, B.; Smith, O.P., 2010:
Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia

Raffaghello, L.; Bianchi, G.; Pistoia, V., 2012:
Immunosuppressive treatments in acute myocardial infarction and stroke

Okuda, D.T., 2014:
Immunosuppressive treatments in multiple sclerosis

Wiser, I.; Orr, N.; Kaufman, B.; Segev, S.; Smetana, Z.; Bialik, A.; Epstein, N.; Mendelson, E.; Catane, R.; Cohen, D., 2010:
Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer

Thervet, E.; Zuber, J.; Sberro, R.; Canaud, G.; Anglicheau, D.; Snanoudj, R.; Mamzer-Bruneel, M-France.; Martinez, F.; Legendre, C., 2012:
Immunosuppressive treatments: mechanisms of action and clinical use

Ding, L.; Liu, Q.; Hu, J.; Tang, S.; Duan, H., 2010:
Immunosuppressive triterpenes from Tetraena mongolica

Rana, S.; Rogers, L.J.; Halliday, G.M., 2010:
Immunosuppressive ultraviolet-A radiation inhibits the development of skin memory CD8 T cells

Huang, C-Feng.; Ma, L.; Sun, L-Juan.; Ali, M.; Arfan, M.; Liu, J-Wen.; Hu, L-Hong., 2010:
Immunosuppressive withanolides from Withania coagulans

Shao, Y.; Cheng, Z.; Li, X.; Chernaya, V.; Wang, H.; Yang, X-feng., 2015:
Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function

Lapp, T.; Maier, P.; Birnbaum, F.; Schlunck, G.; Reinhard, T., 2015:
Immunosuppressives to prevent rejection reactions after allogeneic corneal transplantation

Albiñana, V.; Sanz-Rodríguez, F.; Recio-Poveda, Lía.; Bernabéu, C.; Botella, L.M., 2011:
Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells

Piccolo-Johanning, L.; Kellerman-Guterman, V.; Valerio-Campos, I.; Chinchilla-Carmona, M., 2013:
Immunosuppressor effect of Trypanosoma musculi (Mastigophora: Trypanosomatidae) on experimental toxoplasmosis

Hourmant, M., 2008:
Immunosuppressor treatment in kidney transplantation from a live donor

Sánchez-Fructuoso, A.I., 2008:
Immunosuppressors

Morjani, H.; Madoulet, C., 2010:
Immunosuppressors as multidrug resistance reversal agents

Zhu, X.; Herrera, G.; Ochoa, J.B., 2010:
Immunosupression and infection after major surgery: a nutritional deficiency

Vince, A.; Dusek, D., 2008:
Immunosupression and viral infections in rheumatic diseases

Chatterjee, K.; Sen, C., 2014:
Immunosupression for patients of endocarditis with glomerulonephritis

Tseĭlikman, V.É.; Filimonova, T.A.; Sibiriak, S.V.; Sinitskiĭ, A.I.; Kozochkin, D.A.; Strel'nikova, L.A., 2011:
Immunosupressive effect of hypokinetic stress and sensitization of thymus to glucocorticoids

Echeverri, C.Velez.; Valencia, G.Adolfo.Zuluaga.; Higuita, L.Maria.Serna.; Gayubo, A.Katherina.Serrano.; Ochoa, C.Lucia.; Rosas, L.Fernanda.Rojas.; Muñoz, L.Carolina.; Sierra, J.; Zuleta, J.Jairo.; Ruiz, J.José.Vanegas., 2014:
Immunosupressive therapy in children with steroid-resistant nephrotic syndrome: single center experience

Pavkovic, M.; Jovanovic, R.; Petrusevska, G.; Cevreska, L.; Stojanovic, A., 2016:
Immunosupressive treatment with cyclosporin-A for a patient with hypoplastic myelodisplastic syndrome: a case report

Nagy, A.; Gertsenstein, M.; Vintersten, K.; Behringer, R., 2006:
Immunosurgery: Isolating the Inner Cell Mass (ICM) of Blastocysts

Senovilla, L.; Galluzzi, L.; Marino, G.; Vitale, I.; Castedo, M.; Kroemer, G., 2013:
Immunosurveillance against cancer-associated hyperploidy

Boilève, A.; Senovilla, L.; Vitale, I.; Lissa, D.; Martins, I.; Métivier, D.; van den Brink, S.; Clevers, H.; Galluzzi, L.; Castedo, M.; Kroemer, G., 2013:
Immunosurveillance against tetraploidization-induced colon tumorigenesis

Mincheff, M., 2010:
Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"?

Senovilla, L.; Galluzzi, L.; Zitvogel, L.; Kroemer, G., 2014:
Immunosurveillance as a regulator of tissue homeostasis

Schadler, K.L.; Crosby, E.J.; Zhou, A.Yao.; Bhang, D.Ha.; Braunstein, L.; Baek, K.Hyuck.; Crawford, D.; Crawford, A.; Angelosanto, J.; Wherry, E.John.; Ryeom, S., 2014:
Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1

Larcher, C.; Frizzera, E.; Pretto, P.; Lang, M.; Sonnleitner, N.; Huemer, H.P., 2012:
Immunosurveillance for Mycobacterium tuberculosis of health care personnel in a third level care hospital

Fridman, W.Herman.; Mlecnik, B.; Bindea, G.; Pagès, F.; Galon, Jérôme., 2011:
Immunosurveillance in human non-viral cancers

Yoshimoto, T.; Mizoguchi, I.; Katagiri, S.; Tauchi, T.; Furusawa, J-Ichi.; Chiba, Y.; Mizuguchi, J.; Ohyashiki, J.H.; Ohyashiki, K., 2014:
Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse

Sauer, K.A.; Maxeiner, J.H.; Karwot, R.; Scholtes, P.; Lehr, H.A.; Birkenbach, M.; Blumberg, R.S.; Finotto, S., 2008:
Immunosurveillance of lung melanoma metastasis in EBI-3-deficient mice mediated by CD8+ T cells

Clark, C.E.; Beatty, G.L.; Vonderheide, R.H., 2008:
Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer

Iannello, A.; Raulet, D.H., 2014:
Immunosurveillance of senescent cancer cells by natural killer cells

Sagiv, A.; Krizhanovsky, V., 2014:
Immunosurveillance of senescent cells: the bright side of the senescence program

Malamut, G., 2008:
Immunosurveillance: a new prognostic factor in colorectal cancer

Cattaneo, A., 2013:
Immunosympathectomy as the first phenotypic knockout with antibodies

Varshavskiĭ, V.A.; Golitsina, E.P.; Meteleva, N.A., 2009:
Immunotactoid glomerulonephritis

Gupta, A.; Khaira, A., 2011:
Immunotactoid glomerulopathy and tuberculosis: a novel association

Nasr, S.H.; Fidler, M.E.; Cornell, L.D.; Leung, N.; Cosio, F.G.; Sheikh, S.S.; Amir, A.A.; Vrana, J.A.; Theis, J.D.; Dogan, A.; Sethi, S., 2013:
Immunotactoid glomerulopathy: clinicopathologic and proteomic study

Singh, K., 2009:
Immunotactoid microtubular corneal deposits in bilateral paraprotein crystalline keratopathy

Lisch, W.; Saikia, P., 2011:
Immunotactoid microtubular corneal deposits in bilateral paraprotein crystalline keratopathy and atypical corneal immunoglobulin deposition in a patient with dysproteinemia

Testa, J.E.; Chrastina, A.; Oh, P.; Li, Y.; Witkiewicz, H.; Czarny, M.; Buss, T.; Schnitzer, J.E., 2009:
Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo

Thierry, B.; Al-Ejeh, F.; Brown, M.P.; Majewski, P.; Griesser, H.J., 2009:
Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells

Yamada, T.; Someya, T.; Fujita, S., 2009:
Immunotargeting of apolipoprotein E in amyloid: an initial trial in mice

Lu, Y-ling.; Yang, B-xia.; Yin, Z-ning., 2011:
Immunotargeting of collagenase on thrombus

Nowak, K.; Kölbel, H.C.; Metzger, R.P.; Hanusch, C.; Frohnmeyer, M.; Hohenberger, P.; Danilov, S.M., 2012:
Immunotargeting of the pulmonary endothelium via angiotensin-converting-enzyme in isolated ventilated and perfused human lung

Maurer, M.; Somasundaram, R.; Herlyn, M.; Wagner, S.N., 2012:
Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches

Inglis, J.R., 1983:
Immunotechnology and industry

Pedrazzoli, P.; Secondino, S.; Perfetti, V.; Comoli, P.; Montagna, D., 2011:
Immunotherapeutic Intervention against Sarcomas

Smaldone, M.C.; Gingrich, J.R., 2011:
Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer

Ruiz, R.; Hunis, B.; Raez, L.E., 2015:
Immunotherapeutic agents in non-small-cell lung cancer finally coming to the front lines

Gandhi, G.Y.; Murad, M.Hassan.; Flynn, D.N.; Elamin, M.B.; Erwin, P.J.; Montori, V.M.; Kudva, Y.C., 2008:
Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials

Khan, M.L.; Halfdanarson, T.R.; Borad, M.J., 2015:
Immunotherapeutic and oncolytic viral therapeutic strategies in pancreatic cancer

Vollmer, Jörg.; Krieg, A.M., 2009:
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

Croce, M.; Orengo, A.Maria.; Azzarone, B.; Ferrini, S., 2013:
Immunotherapeutic applications of IL-15

Tsutsui, H.; Nakanishi, K., 2013:
Immunotherapeutic applications of IL-18

Kuppala, M.Babu.; Syed, S.Begum.; Bandaru, S.; Varre, S.; Akka, J.; Mundulru, H.Prasad., 2013:
Immunotherapeutic approach for better management of cancer--role of IL-18

Bagnato, B.; Marino, M.Giulia.; Franco, E., 2013:
Immunotherapeutic approach for the prevention and treatment of chronic diseases

Bowne, W.B.; Hawkins, W.G.; Lewis, J.J., 2001:
Immunotherapeutic approach to cancer with cutaneous DNA vaccination

Ursu, R.; Carpentier, A.F., 2012:
Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma

Verkaik, N.J.; van Wamel, W.J.B.; van Belkum, A., 2011:
Immunotherapeutic approaches against Staphylococcus aureus

Wisniewski, T.; Boutajangout, A., 2010:
Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models

Okada, H.; Kohanbash, G.; Zhu, X.; Kastenhuber, E.R.; Hoji, A.; Ueda, R.; Fujita, M., 2009:
Immunotherapeutic approaches for glioma

Cianferoni, A.; Spergel, J.M., 2015:
Immunotherapeutic approaches for the treatment of eosinophilic esophagitis

McClanahan, F.; Gribben, J.G., 2013:
Immunotherapeutic approaches have the potential to brighten the future not only for patients with del(17p13.1), but for all CLL patients

Guilhot, Fçois.; Roy, L.; Saulnier, P-Jean.; Guilhot, Jëlle.; Barra, A.; Gombert, J-Marc.; Turhan, A., 2008:
Immunotherapeutic approaches in chronic myelogenous leukemia

Stieler, J., 2007:
Immunotherapeutic approaches in pancreatic cancer

Brazier, M.W.; Mot, A.I.; White, A.R.; Collins, S.J., 2013:
Immunotherapeutic approaches in prion disease: progress, challenges and potential directions

Dawson, N., 2011:
Immunotherapeutic approaches in prostate cancer: PROVENGE

Miamen, A.G.; Dong, H.; Roberts, L.R., 2013:
Immunotherapeutic approaches to hepatocellular carcinoma treatment

Tsirigotis, P.; Or, R.; Resnick, I.B.; Shapira, M-Yechiel., 2012:
Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease

Roeven, M.W.H.; Hobo, W.; Schaap, N.; Dolstra, H., 2016:
Immunotherapeutic approaches to treat multiple myeloma

Kameshima, H.; Tsuruma, T.; Kutomi, G.; Shima, H.; Iwayama, Y.; Kimura, Y.; Imamura, M.; Torigoe, T.; Takahashi, A.; Hirohashi, Y.; Tamura, Y.; Tsukahara, T.; Kanaseki, T.; Sato, N.; Hirata, K., 2013:
Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients

Féraudet-Tarisse, Cécile.; Andréoletti, O.; Morel, N.; Simon, Séphanie.; Lacroux, C.; Mathey, J.; Lamourette, P.; Relaño, A.; Torres, J.Maria.; Créminon, C.; Grassi, J., 2010:
Immunotherapeutic effect of anti-PrP monoclonal antibodies in transmissible spongiform encephalopathy mouse models: pharmacokinetic and pharmacodynamic analysis

Liu, D.; Tang, L.; Zhou, C-Cun.; Tan, L-Song., 2007:
Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors

Francisco-Cruz, A.; Mata-Espinosa, D.; Estrada-Parra, S.; Xing, Z.; Hernández-Pando, R., 2013:
Immunotherapeutic effects of recombinant adenovirus encoding granulocyte-macrophage colony-stimulating factor in experimental pulmonary tuberculosis

Awais, M.Muhammad.; Akhtar, M.; Muhammad, F.; ul Haq, A.; Anwar, M.Irfan., 2011:
Immunotherapeutic effects of some sugar cane (Saccharum officinarum L.) extracts against coccidiosis in industrial broiler chickens

Tan, G.; Wang, Z.; Che, L.; Yin, S., 2007:
Immunotherapeutic effects on murine pancreatic carcinoma by β-elemene combined with dendritic cells modified with genes encoding interleukin-23

Rakshit, S.; Ponnusamy, M.; Papanna, S.; Saha, B.; Ahmed, A.; Nandi, D., 2012:
Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNγ

Wang, P.; Wang, L.; Zhang, W.; Bai, Y.; Kang, J.; Hao, Y.; Luo, T.; Shi, C.; Xu, Z., 2015:
Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice

Guan, X.; Yang, J.; Gu, H.; Zou, J.; Yao, Z., 2014:
Immunotherapeutic efficiency of a tetravalent Aβ1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease

Tanaka, T.; Kishimoto, T., 2012:
Immunotherapeutic implication of IL-6 blockade

Griesinger, A.M.; Donson, A.M.; Foreman, N.K., 2014:
Immunotherapeutic implications of the immunophenotype of pediatric brain tumors

Wang, L.; Zou, Z.Qiang.; Liu, C.Xia.; Liu, X.Zhong., 2014:
Immunotherapeutic interventions in chronic hepatitis B virus infection: a review

Taylor, R.P.; Lindorfer, M.A., 2008:
Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies

Chan, T.; Wiltrout, R.H.; Weiss, J.M., 2011:
Immunotherapeutic modulation of the suppressive liver and tumor microenvironments

Shaffer, D.R.; Rooney, C.M.; Gottschalk, S., 2011:
Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation

Compte, M.; Nuñez-Prado, N.; Sanz, L.; Alvarez-Vallina, Lís., 2014:
Immunotherapeutic organoids: a new approach to cancer treatment

Ramqvist, Törn.; Dalianis, T., 2010:
Immunotherapeutic polyoma and human papilloma virus-like particles

Manuja, A.; Manuja, B.K.; Kaushik, J.; Singha, H.; Singh, R.Kumar., 2014:
Immunotherapeutic potential of CpG oligodeoxynucleotides in veterinary species

Mir, S.Ahmad.; Sharma, S., 2014:
Immunotherapeutic potential of N-formylated peptides of ESAT-6 and glutamine synthetase in experimental tuberculosis

Zhang, B.; Yin, Y.; Lai, R.Chai.; Lim, S.Kiang., 2014:
Immunotherapeutic potential of extracellular vesicles

Malley, A., 1983:
Immunotherapeutic potential of idiotype/anti-idiotype regulation of the IgE response

Angus, A.G.N.; Patel, A.H., 2011:
Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2

Thorne, S.H., 2014:
Immunotherapeutic potential of oncolytic vaccinia virus

Prestwich, R.J.; Harrington, K.J.; Vile, R.G.; Melcher, A.A., 2008:
Immunotherapeutic potential of oncolytic virotherapy

Mir, S.Ahmad.; Verma, I.; Sharma, S., 2014:
Immunotherapeutic potential of recombinant ESAT-6 protein in mouse model of experimental tuberculosis

Kim, J.Myung.; Han, S.Hoon., 2011:
Immunotherapeutic restoration in HIV-infected individuals

Schmidt, S.; Tramsen, L.; Schneider, A.; Balan, A.; Lehrnbecher, T., 2015:
Immunotherapeutic strategies against mucormycosis in haematopoietic stem cell transplantation

Haynes, N.M.; Smyth, M.J., 2012:
Immunotherapeutic strategies as adjuncts to local radiotherapy

Solomon, B., 2009:
Immunotherapeutic strategies for Alzheimer's disease treatment

Chevalier, M.F.; Nardelli-Haefliger, D.; Domingos-Pereira, S.; Jichlinski, P.; Derré, L., 2016:
Immunotherapeutic strategies for bladder cancer

Shashidharamurthy, R.; Bozeman, E.N.; Patel, J.; Kaur, R.; Meganathan, J.; Selvaraj, P., 2013:
Immunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development

Sharma, P.; Old, L.J.; Allison, J.P., 2007:
Immunotherapeutic strategies for high-risk bladder cancer

Alexeev, V.; Mucci, T.; Igoucheva, O., 2008:
Immunotherapeutic strategies for the treatment of malignant melanoma

Bedke, J.; Stenzl, A., 2014:
Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?

Papotto, P.Henrique.; Marengo, E.Blini.; Sardinha, L.Roberto.; Goldberg, A.Carla.; Rizzo, L.Vicente., 2015:
Immunotherapeutic strategies in autoimmune uveitis

Clark, R.E., 2010:
Immunotherapeutic strategies in chronic myeloid leukemia

Gribben, J.G.; Riches, J.C., 2014:
Immunotherapeutic strategies including transplantation: eradication of disease

Ohlsen, K.; Lorenz, U., 2010:
Immunotherapeutic strategies to combat staphylococcal infections

Magee, M.S.; Snook, A.E.; Marszalowicz, G.P.; Waldman, S.A., 2013:
Immunotherapeutic strategies to target prognostic and predictive markers of cancer

Jorritsma, A.; Schumacher, T.N.M.; Haanen, J.B.A.G., 2011:
Immunotherapeutic strategies: the melanoma example

Muller, A.J.; DuHadaway, J.B.; Jaller, D.; Curtis, P.; Metz, R.; Prendergast, G.C., 2010:
Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate

Mallick, A.; Barik, S.; Ghosh, S.; Roy, S.; Sarkar, K.; Bose, A.; Baral, R., 2015:
Immunotherapeutic targeting of established sarcoma in Swiss mice by tumor-derived antigen-pulsed NLGP matured dendritic cells is CD8+ T-cell dependent

Gehrmann, M.; Stangl, S.; Kirschner, A.; Foulds, G.A.; Sievert, W.; Doss, B.T.; Walch, A.; Pockley, A.G.; Multhoff, G., 2012:
Immunotherapeutic targeting of membrane Hsp70-expressing tumors using recombinant human granzyme B

Arakaki, R.; Ishimaru, N.; Hayashi, Y., 2010:
Immunotherapeutic targets in estrogen deficiency-dependent Sjögren's syndrome-related manifestations

Kim, J.Hyeon.; Jin, S-Man.; Kim, H.Sik.; Kim, K-Ah.; Lee, M-Shik., 2014:
Immunotherapeutic treatment of autoimmune diabetes

Das, S.; Raizer, J.J.; Muro, K., 2008:
Immunotherapeutic treatment strategies for primary brain tumors

Anonymous, 2010:
Immunotherapeutic vaccine extends life of prostate cancer patients

Criscitiello, C.; Curigliano, G., 2014:
Immunotherapeutics for breast cancer